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ABSTRACT OF THE DISSERTATION 
SYNTHESIS OF AROMATIC MONOTHIOLS AND AROMATIC DITHIOLS  
TO INCREASE THE FOLDING RATE AND YIELD OF  
DISULFIDE CONTAINING PROTEINS 
by 
Amar S. Patel 
Florida International University, 2010 
Miami, Florida, 
Professor Watson J. Lees, Major Professor 
Most pharmaceutically relevant proteins and many extracellular proteins contain 
disulfide bonds. Formation of the correct disulfide bonds is essential for stability in 
almost all cases. Disulfide containing proteins can be rapidly and inexpensively 
overexpressed in bacteria. However, the overexpressed proteins usually form aggregates 
inside the bacteria, called inclusion bodies, which contains inactive and non-native 
protein. To obtain native protein, inclusion bodies need to be isolated and resolubilized, 
and then the resulting protein refolded in vitro. In vitro protein folding is aided by the 
addition of a redox buffer, which is composed of a small molecule disulfide and/or a 
small molecule thiol. The most commonly used redox buffer contains reduced and 
oxidized glutathione. Recently, aliphatic dithiols and aromatic monothiols have been 
employed as redox buffers. Aliphatic dithiols improved the yield of native protein as 
compared to the aliphatic thiol, glutathione. Dithiols mimic the in vivo protein folding 
catalyst, protein disulfide isomerase, which has two thiols per active site. Furthermore, 
aromatic monothiols increased the folding rate and yield of lysozyme and RNase A 
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relative to glutathione. By combining the beneficial properties of aliphatic dithiols and 
aromatic monothiols, aromatic dithiols were designed and were expected to increase in 
vitro protein folding rates and yields. 
 Aromatic monothiols (1-4) and their corresponding disulfides (5-8), two series of 
ortho- and para-substituted ethylene glycol dithiols (9-15), and a series of aromatic 
quaternary ammonium salt dithiols (16-17) were synthesized on a multigram scale. 
Monothiols and disulfides (1-8) were utilized to fold lysozyme and bovine pancreatic 
trypsin inhibitor. Dithiols (11-17) were tested for their ability to fold lysozyme. At pH 7.0 
and pH 8.0, and high protein concentration (1 mg/mL), aromatic dithiols (16, 17) and a 
monothiol (3) significantly enhanced the in vitro folding rate and yield of lysozyme 
relative to the aliphatic thiol, glutathione. Additionally, aromatic dithiols (16, 17) 
significantly enhance the folding yield as compared to the corresponding aromatic 
monothiol (3). Thus, the folding rate and yield enhancements achieved in in vitro protein 
folding at high protein concentration will decrease the volume of renaturation solution 
required for large scale processes and consequently reduce processing time and cost. 
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Chapter 1 
Introduction 
1.1 Introduction 
Proteins are the most abundant organic molecules in living organisms. They occur 
in every part of the cell and constitute about 50% of cellular dry weight. Proteins form 
the fundamental basis of life.1 The human body contains approximately 100,000 different 
types of proteins, and each protein has its own function, such as catalysis, transport and 
storage of small molecules and ions, growth control, and mechanical support. 
Furthermore, proteins perform regulatory roles including monitoring extracellular and 
intracellular conditions, and passing information to other cellular components. One 
striking feature is that most known enzymes are proteins. Enzymes are macromolecules 
that catalyze most of the chemical reactions in biological systems, and can increase 
reaction rates by many orders of magnitude.  
Proteins are composed approximately 20 different amino acids, and each amino 
acid is connected to another by a peptide bond to form a polypeptide chain.1 The structure 
of proteins is divided into four levels (Figure 1): 
a) Primary structure is the sequence of amino acids joined by peptide bonds to 
form a polypeptide chain; 
b) Secondary structure refers to the spatial arrangement of amino acids residues 
that are nearby in the sequence, these arrangements are regular and give rise to 
alpha helices and beta sheets; 
c) Tertiary structure refers to the spatial arrangement of amino acids residues that 
are far apart in the sequence and to the pattern of disulfide bonds; 
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d) Quaternary structure refers to the spatial arrangement of polypeptide chains and 
the nature of their interaction. 
                          
 
Figure 1. Diagrammatic representation of the stages of protein formation. a) Primary 
structure, b) Secondary structure, c) Tertiary structure of myoglobin, and d) Quaternary 
structure of hemoglobin. Figure from Griffiths, W., 1999.2 
 
Proteins are initially synthesized as linear polypeptide chains that are eventually 
extruded from ribosome. At this stage, the proteins are considered to be nonnative and 
nonfunctional. In order to become native and functional, proteins have to shield their 
exposed hydrophobic residues and adopt a precise tertiary structure. It is well known that 
the primary amino acid sequence determines the tertiary structure of proteins, but how 
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folding occurs to form native protein is still the subject of intense investigation. Many 
experiments have been conducted to gain insight into how proteins efficiently acquire 
their three dimensional structure.3 Additionally, an understanding of protein folding 
would provide a basis for the design of proteins and help in structure prediction from the 
amino acids sequence. 
 Although the amino acid sequence specifies the tertiary structure of proteins, the 
formation of native disulfide bonds plays an important role in the biosynthesis of many 
extracellular proteins including most pharmaceutically relevant proteins.4 The formation 
of the correct disulfide bonds between cysteine residues is essential for stability and 
activity in almost all cases. Disulfide bonds stabilize the native three dimensional 
structure of proteins by lowering the entropy of the unfolded state and by forming 
energetically favorable interactions in the native state.5 Failure to form the correct 
disulfide bonds may lead to protein misfolding, aggregation, and degradation by 
proteases which can result in various neurodegenerative diseases.6  
1.2 Importance of protein folding 
1.2.1 Protein misfolding diseases  
 Protein folding and unfolding are coupled to many significant events in the 
functioning of a biological systems, including translocation of proteins across 
membranes, secretion of extracellular proteins, protein trafficking, and the control and 
regulation of the cell cycle.7 Many human diseases arise from the failure of a specific 
peptide or protein to adopt or remain in its native functional conformational state, which 
leads to protein aggregation. These pathological disorders are generally referred to as 
protein misfolding diseases and recently, were grouped under the name of protein 
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conformational disorders (PCDs).8 The diseases in this group include Alzheimer's 
disease, transmissible spongiform encephalopathies, Hungtington disease, cystic fibrosis, 
type II diabetes, mad cow disease, Parkinson’s disease, Crutzfeldt-Jacob disease, and 
cancer.6,9-12 The characteristic feature of PCDs is a change in the secondary and/or 
tertiary structure of a normal protein without any change in the primary structure. These 
conformational changes may lead to various diseases by either the gain of toxic activity 
or by the loss of biological activity (Figure 2).13,14 
 
 
 
Figure 2. Schematic representation of protein misfolding which may results in diseases 
from Soto, C., 2001.10  
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1.2.2 Protein folding by recombinant technology 
Recombinant DNA technology allows the large scale synthesis of proteins for 
both research and industrial purposes. Recombinant technology, which was developed 
from decades of basic research on the nature of DNA, has allowed the synthesis of many 
useful proteins such as insulin and provided a vital tool for studying gene activity. 15 With 
biotechnology, high value proteins can be overexpressed in bacteria in a rapid and 
inexpensive way. However, overexpressed proteins, especially disulfide containing 
proteins, can be deposited as insoluble inactive aggregates (inclusion bodies) in the host 
cell. The protein within these aggregates is usually inactive and non-native. To obtain the 
native protein, it is necessary to isolate the aggregates, resolubilize the protein, and fold 
the protein in vitro (Figure 3).16 The formation of the correct disulfide bonds during in 
vitro protein folding is the slowest and the rate-determining step. 
Active Protein
Inclusion Bodies
(Inactive protein)E.coli
Induction Purification
Inclusion Bodies
(Inactive protein)
1) Isolation
2) Solubilization
3) In vitro folding
 
Figure 3. Protein expression by recombinant DNA technology. 
 
The common process to recover native protein from inclusion bodies involves 3 
steps: 
  6 
 
a)  Isolation of inclusion bodies- Inclusion bodies have relatively high specific density, 
and thus can be harvested after cell lysis by centrifugation at moderate rotor speeds.17  
b) Inclusion bodies solubilization- Solubilization of inclusion bodies can be 
accomplished using strong denaturants such as 6 M guanidium HCl (Gdn HCl) or 6-8 
M urea, which disrupts noncovalent bonds between polypeptide chains.18 Two 
reasons Gdn HCl preferred over urea are: First, Gdn HCl is a strong chaotroph, which 
can solubilize strong sturdy inclusion bodies; Second, urea may decompose to give 
cyanate ions, which can irreversibly modify the amino acids residues of the protein 
especially upon long term incubation at alkaline pH.19 The isolated inclusion bodies 
of cysteine containing proteins usually contain interchain disulfide bonds which 
reduce solubility of the inclusion bodies.20 Thus, low molecular weight thiol reagents 
are usually added in combination with chaotrophs to reduce the interchain disulfide 
bonds by thiol/disulfide interchange reactions. Thiol reagents such as dithiothreitol, 
dithioerythritol, glutathione, cysteine, cystamine, or 2-mercaptoethanol can be 
employed. Furthermore, detergents have also been used to solubilize inclusion bodies. 
Most commonly used detergents are sodium dodecyl sulfate (SDS) and n-cetyl 
trimethylammonium bromide (CTAB).21 
c)  Refolding of solubilized protein- The refolding step should be optimized for each 
protein in order to get the highest yield of active protein. The general procedure for 
refolding involves the removal of denaturant, thereby allowing the polypeptide to 
recover its native structure. Denaturant can be removed by several methods including 
dilution, dialysis, diafiltration gel filtration, and immobilization on solid support. The 
dilution method involves diluting the denatured protein solution into refolding buffer 
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which reduces the chaotrope concentration and provides a suitable environment for 
the protein to refold. Dilution has been used to fold many proteins such as antibody 
fragments, interleukin 2, M-CSF, and pro-urokinase.22-25 The major drawback of the 
dilution method is the requirement for large processing volumes which increases the 
overall cost. In dialysis, the concentration of denaturant is reduced by dialyzing 
against refolding buffer. As the concentration of chaotrope decreases, the protein 
starts to refold. Dialysis membranes are semi-permeable membranes, which allow the 
transport of small molecules across the membrane and retain the large molecules. The 
process is driven by the osmotic pressure difference across the membrane. Examples 
of proteins folded by dialysis are  citrate  synthase, chymotrypsinogen, and urokinase. 
26-28 As the process of dialysis is controlled by osmotic pressure, dialysis may be too 
slow to be employed in commercial scale production of proteins. As an alternative, 
diafiltration can be used for removal of denaturant and refolding of proteins. 
Diafiltration is a pressure driven process using ultrafiltration membranes of specific 
membrane size which allows the transport of small molecule chaotrope across the 
membrane while retaining the protein. Simultaneously, refolding buffer is added at 
the same rate as solvent passes through the membrane. Examples of proteins folded 
by diafiltration are prorennin and carbonic anhydrase.28,29 
1.3 Background 
1.3.1 Thiol/disulfide interchange reaction 
Most pharmaceutically relevant proteins and many extracellular proteins contain 
disulfide bonds. When these proteins are overexpressed in bacteria, they usually produce 
inclusion bodies. To obtain these proteins in their biologically active form, it is necessary 
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to resolubilize the inclusion bodies and then fold the protein in vitro. In in vitro protein 
folding, a significant challenge is the formation of the correct disulfide bonds between 
cysteine residues. Disulfide bonds are the only covalent bonds formed during folding and 
their formation is usually slow and thus the rate determining step. Disulfide bond 
formation involves thiol/disulfide interchange reactions as shown in scheme 1. The 
mechanism involves the nucleophilic attack of a thiolate anion (R1S¯) on a disulfide bond 
(R2SSR3), displacing one sulfur (R3S) of the disulfide bond and forming a new disulfide 
bond (R1SSR2). R3S¯ acts as the leaving group and R2S acts as the center sulfur.5 As the 
number of cysteine residues increases, the probability of forming non-native disulfide 
bonds increases exponentially.  
         
 
R1 S S S
R2 R3
R3 S
S S
R1 R2
 
         Thiolate             Disulfide bond                     New disulfide bond      Leaving group 
Scheme 1. Mechanism for thiol/disulfide interchange reaction 
 
To enhance the in vitro folding rate of disulfide containing proteins, protein 
catalysts and a limited number of small molecule thiols have been used.4,5,30-33 Protein 
catalysts, such as protein disulfide isomerase (PDI), which is used in vivo, can increase in 
vitro protein folding rates significantly. However, the use of PDI for in vitro folding is 
impractical because of its high cost and the amount of PDI required to achieve significant 
rate enhancements.31 Small molecule aliphatic thiols, such as glutathione (GSH), 
cysteine, and dithiothreitol (DTT) are usually employed for in vitro protein folding.5,33 A 
small molecule thiol is generally used in combination with a small molecule disulfide, to 
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form a redox buffer, for example oxidized glutathione (GSSG) and reduced glutathione 
(GSH). Although protein folding rates with small molecule thiols are slower than those 
obtained with PDI, small molecule thiols are less expensive and can easily be removed 
from the native protein. Recently, more efficient redox buffers containing aliphatic 
dithiols, synthetic peptides, or aromatic monothiols have been employed as redox 
buffers.32,34-38  
S2S1 S2S1 S2S1 S2S1
R S3
R S3 S3 R S3
R
1 2 3Protein Protein Protein Protein
 
Scheme 2. Role of redox buffer thiol in thiol/disulfide interchange reactions, where the 
redox buffer thiol (R-S3) can act as 1) a nucleophile, 2) a center thiol, and 3) a leaving 
group.39 
 
The folding pathways of several disulfide containing proteins have been well 
characterized.5,40-42 Each of these pathways involves multiple thiol/disulfide interchange 
reactions between the protein and small molecule thiols and disulfides. Several factors 
may influence the rate of formation of disulfide bonds, such as the concentration of the 
thiolate anions, accessibility, proximity, and reactivity of the thiol group and disulfide 
bonds.5,41 The concentration of the thiolate anion depends on several factors such as total 
thiol concentration, the thiol pKa, and the solution pH.35 The thiol in its deprotonated 
form can act as a nucleophile or a leaving group, and thiol in a disulfide can act as a 
center thiol (Scheme 2).35 Disulfide bond formation can be inhibited by the burial of 
reactive groups, such as protein thiol groups, protein disulfide bonds, and mixed disulfide 
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bonds, in a stable tertiary structure. For instance, the burial of the disulfide bonds in 
stable tertiary structures prevents their reduction and reshuffling. On the other hand, the 
segregation of two protein thiols can inhibit the formation of a disulfide bond between 
them. Thus, stable tertiary structures can inhibit the contacts between the thiolates and 
disulfides and thereby affect their reactivity.    
The thiol/disulfide interchange reaction can occur intramolecularly, that is within 
the protein itself, or intermolecularly between the protein and the redox buffer.5 During 
the in vitro folding of disulfide containing proteins, there are 8 possible types of the 
thiol/disulfide interchange reaction that can occur. In the first four reactions (Figure 4, A-
D), the protein thiolate acts as a nucleophile, while the small molecule thiolate acts as a 
nucleophile in the last four reactions (Figure 4, E-H). The thiolates can nucleophilically 
attack one of several disulfides, a protein disulfide (Figure 4, A and E); a small molecule 
disulfide (Figure 4, B and F); a mixed disulfide between a small molecule thiol and a 
protein thiol at either the sulfur attached to the protein (Figure 4, C and G) or the small 
molecule (Figure 4, D and H).  
Moreover, the rates of almost all of the thiol/disulfide interchange reactions can 
be increased by aromatic thiols compared to aliphatic thiols under standard conditions. 
The reasons are that aromatic thiols are better nucleophiles, better leaving groups, and 
better center thiols than aliphatic thiols such as glutathione at pH 7.0 or 7.7.43,44 Aromatic 
thiolates are better nucleophiles than aliphatic thiolates with similar thiol pKa values.43 
Moreover, the leaving group ability of thiols is inversely proportional to the thiol pKa. 
Thus, aromatic thiols are better leaving group than glutathione as aromatic thiols have 
lower thiol pKa values than glutathione.43 
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Figure 4. Thiol/disulfide interchange reactions with a small molecule thiol (RSH) and a 
small molecule disulfide (RSSR) that occur during in vitro protein folding.37 
1.3.2 Protein disulfide isomerase 
Protein disulfide isomerase (PDI), a 57 kDa protein, is a member of a large family 
of dithiol/disulfide oxidoreductases, the thioredoxin superfamily.45 Protein disulfide 
isomerase is found in a number of living organisms, such as fungi, plants, and animals. 46 
Protein disulfide isomerase is constitutively expressed in many tissues and organs and 
retained in the lumen of the endoplasmic reticulum in high concentrations. In the 
endoplasmic reticulum, PDI catalyzes the formation, reduction, and isomerization of 
disulfide bonds in newly synthesized proteins.47 Additionally, PDI also shows chaperone 
activity, by preventing the aggregation of unfolded proteins, and is a member of two 
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multimeric enzyme complexes, prolyl 4-hydroxylase and microsomal triglyceride transfer 
protein.48-50   
1.3.2.1 Structure of PDI 
  
a b b' x a' c
134-136 233-235 349-369 479
50818
24  
Figure 5. Domains of human PDI, numbering is for full length human PDI.51  
Human PDI consists of 491 amino acids and has four distinct domains, a, b, b’, 
and a’, plus a highly acidic C-terminal extension c and a 19-amino acid interdomain 
linker between the b’ and a’ domains called x (Figure 5).51 The catalytic a and a’ 
domains are homologous to thioredoxin, and each domain contains an independent active 
site. Each active site contains two cysteine molecules in the sequence Cys-Gly-His-Cys 
(CGHC), which mediates PDI's acitivities.52 The b and b’ domains are similar in 
sequence to each other but different from thioredoxin and redox inactive. The function of 
b’ domain is to bind substrate proteins.53 The cationic c domain is not essential for 
enzymatic activity and ends with a C-terminal endoplasmic reticulum retention signal 
(KDEL in rat and human, HDEL in yeast).54,55 The crystal structure of human PDI is 
unknown, although structures of individual a and b domains of human PDI have been 
determined by NMR spectroscopy.56,57 These studies showed that not only the a domain 
but also the b domain adopts the thioredoxin fold. However, the three dimensional 
arrangement of the four thioredoxin domains and their respective functions in the 
catalytic mechanism are still unknown. 
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Figure 6. a, b, b’, and a’ domains of PDI are represented in magenta, cyan, yellow, and 
red, respectively, and C-terminal extension is represented in green. The orientation of the 
two structures differ by a 90° rotation around the horizontal axis. In the a and a’ domains, 
the side chains of active site cysteines are revealed in space filling representation with the 
sulfur atoms in yellow color. Figure from Tian, G. et al., 2006.58 
 
 
Recently, Tian et al. have determined the crystal structure of full length yeast PDI 
at 2.4 Å resolution, the first complete PDI structure.58 The crystal structure of PDI adopts 
the shape of the letter "U" although in twisted form. The a and a’ domains lies on the end 
of the "U" and the b and b’ domains form the base (Figure 6). The width and height of 
the molecule "U" is ~80 Å and ~60 Å, respectively. According to the crystal structure, 
each of the domains, a, a’, b, and b’, adopts the thioredoxin fold with minor changes 
(Figure 7I). The prototypical thioredoxin fold consists of a five stranded β sheet with two 
α helices on each side (Figure 7II). 
In vivo, disulfide bond formation is catalyzed by PDI. Protein disulfide isomerase 
contains two cysteine thiol groups (two cysteine separated by two amino acids, CXXC) in 
each active site. One cysteine thiol is solvent exposed and the other thiol is buried. The 
solvent exposed thiol has a low pKa value, 6.7, and is relatively reactive with disulfide 
bonds compared to small molecule aliphatic thiols, such as glutathione. The other thiol 
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has a high thiol pKa value and is buried inside the protein. However, the use of PDI for in 
vitro folding of disulfide containing protein is limited because of its cost and low 
catalytic activity (kcat = ~ 1 min -1).31  
 
             
                        I                                                                                 II 
Figure 7. I) Structure of a, a’, b, and b’ domains of PDI. II) The typical thioredoxin fold, 
green represents α helices, red represents β sheets, and red oval indicates the location of 
active site. Figure from Tian, G. et al., 2006.58 
 
1.3.2.2 Chaperone and anti-chaperone activity of PDI in the oxidative folding of 
lysozyme 
One of the most common problems faced in in vitro protein folding of lysozyme 
is aggregation, which results from the low solubility of the unfolded protein or folding 
intermediates.59 Aggregation is also a common phenomenon when disulfide containing 
proteins are overexpressed in vivo. The folding efficiency depends on how the unfolded 
denatured protein partitions between pathways leading to aggregation and pathways 
leading to native protein. In vivo, foldases and molecular chaperones influence the 
partitioning between productive and non-productive folding pathways.60 Foldases 
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increase the folding rate by catalyzing the slow chemical steps such as disulfide 
formation and proline isomerization.61,62 Molecular chaperones do not appreciably 
increase the folding rate, but inhibit non-productive aggregation and misfolding by 
binding to non-native proteins.60,63 In order to inhibit aggregation, molecular chaperones 
must be present in stoichiometric excess as compared to the protein substrate, while 
foldases (e.g. PDI) can function at catalytic concentrations. When the functions of 
foldases and molecular chaperones become unbalanced, productive folding may be 
disturbed leading to protein aggregation and misfolding. Apart from its role as a foldases, 
PDI has two paradoxical roles in substrate aggregation. Protein disulfide isomerase can 
function as a chaperone and inhibit aggregation, or under some conditions, PDI behaves 
as an anti-chaperone and assist in the formation of aggregates. 
Initially, during the folding of lysozyme, when PDI is present in substantial 
stoichiometric excess, PDI can prevent the formation of lysozyme aggregation, 
suggesting that very rapid disulfide formation can divert the denatured protein toward 
productive folding (Figure 8).48 Furthermore, one of the characteristic features of 
molecular chaperone involves the interaction of the chaperone’s nonspecific peptide-
binding site with a denatured protein in a manner which inhibits protein aggregation. A 
nonspecific peptide/protein binding site is present in PDI, which can act as a molecular 
chaperone at high PDI concentrations and inhibit lysozyme aggregation.64-66 
In contrast, under certain conditions, PDI aids in the formation of protein 
aggregates, a behavior known as anti-chaperone activity.67,68 The anti-chaperone activity 
of PDI may be attributed to the interaction between PDI and lysozyme aggregates, which 
facilitates the intermolecular cross linking of additional lysozyme to the aggregate, even 
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for molecules that were previously committed to folding (Figure 8). Intermolecular cross 
linked aggregates between PDI and unfolded protein is usually seen when low 
concentration of PDI is added to a solution of unfolded, reduced lysozyme.67 Thus, PDI 
shows anti-chaperone like activity at low concentration and exhibits chaperone like 
activity at high concentration suggesting the rationale for PDI's high concentration in vivo 
and its low catalytic efficiency. 
                
                Chaperone                                             Anti-chaperone 
Figure 8. Proposed model for the chaperone and anti-chaperone activity of PDI by Puig 
et al., 1994.48 U indicates reduced, denatured lysozyme. Ia and If are denatured lysozyme 
that are committed to aggregation and folding, respectively. N denotes native lysozyme 
and P represents PDI.48 
 
1.3.3 Role of Ero1p and glutathione in oxidative protein folding 
Native disulfide bond formation is an essential step for the folding and stability of 
many secreted proteins. The first step of the process is the oxidation of protein thiols to 
form disulfide bonds, and the next step is the rearrangement of non-native disulfide bonds 
to native ones.40,69 In vitro, oxidative protein folding is spontaneous but slow, taking from 
hours to days.70 However, in vivo, oxidative protein folding is fast, which suggests that 
disulfide bond formation and rearrangement is catalyzed by enzymes in living cells.71 
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Protein disulfide bond formation in eukaryotic cells occurs in the lumen of the 
endoplasmic reticulum (ER).72 The ER contains millimolar concentrations of reduced 
glutathione (GSH) and oxidized glutathione (GSSG), although the exact concentrations 
of both are unknown. The ratio of [GSH]/[GSSG] in the ER ranges from 1:1 to 3:1, while 
in the cytosol, the ratio ranges from 30:1 to 100:1.73 The high concentration of GSH in 
the cytosol disfavors the formation of protein disulfide bonds in the cytosol. On the 
contrary, the more oxidizing conditions in the ER compared to the cytosol 
thermodynamically favors the formation of protein disulfide bonds. The high 
concentration of GSSG in the ER has led to the proposal that GSSG provides the 
oxidizing equivalents that are required during protein disulfide bond formation in vivo.73 
Over the past decade, the perception of the physiologically relevant mechanisms 
for PDI oxidation in vivo has changed. Prior to 1998, GSSG was thought to oxidize PDI 
in vivo, however, by the discovery and subsequent characterization of ER membrane 
associated protein, Ero1p, this viewpoint has been changed.74 Now, it is believed that 
Ero1p provides the oxidizing equivalents necessary for protein disulfide bond formation 
to PDI.74-76 While screening temperature sensitive Saccharomyces cervisiae mutants for 
conditional defects in export of secretory proteins from the ER in yeast, a novel gene 
named Ero1 was identified.74,75 Furthermore, Ero1p driven oxidation of PDI can occur 
independently of glutathione both in vivo and in vitro.74,77 Most importantly, Ero1p and 
PDI form a mixed disulfide in vivo.78 In the ER lumen, flavin adenine dinucleotide (FAD) 
bound Ero1p oxidizes PDI through a thiol/disulfide interchange reaction. In the absence 
of Ero1p, PDI accumulates in its reduced form.77 Ero1p is not the direct oxidant of 
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folding proteins, but relies on PDI to transfer oxidizing equivalents.77 Thus the oxidizing 
equivalents are transferred via the protein relay: Ero1p to PDI to protein (Figure 9). 
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Figure 9. The pathway of native disulfide bond formation in the ER of the lumen by PDI 
via Ero1p. 
 
Genetic evidence in yeast has shown that glutathione is not essential for disulfide 
bond formation, but that glutathione functions as a net reductant in the ER.79 The role of 
glutathione as a reductant was evident from studies in which the synthesis of GSH was 
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prevented. While screening suppressors of the temperature sensitivity of the ero1-1 
mutant, a deletion of GSH1, the first enzyme in the biosynthesis of glutathione, was 
found to strongly suppress the ero1-1 phenotype.79 The absence of glutathione as a 
reductant resulted in less reduction of oxidized PDI and proteins, thus, allowing a 
compromised ero1-1 oxidation system to support growth of yeast. The oxidative protein 
folding of carboxypeptidase Y (CPY), a five disulfide bond containing protein, proceeds 
with normal kinetics in a Δgsh1 strain but is sensitive to oxidative stress, consistent with 
the role of glutathione as a net reductant.79 Additionally, two more studies have shown 
that glutathione has a crucial role in the isomerization of non-native disulfide bonds.80,81 
These studies showed that when the glutathione level in the ER decreases, disulfide bond 
formation increases. However, the increase in the disulfide bond formation is 
accompanied by an increase in non-native disulfide bond formation. Furthermore, a 
decrease in the levels of cytosolic GSH results in PDI becoming more oxidized, limiting 
the ability of PDI to isomerizes non-native disulfide bonds. Thus, it suggests that, directly 
or indirectly, GSH is involved in the isomerization of non-native disulfides.82  
1.3.4 General pathway of protein folding 
Numerous folding studies on model proteins, such as ribonuclease A (RNase A), 
have been conducted to understand the mechanism of protein folding. Some proteins fold 
directly without any intermediate, while others fold via one or more folding 
intermediates. Four general types of protein folding pathways via intermediates were 
proposed by Scheraga et al. (Figure 10) on the basis of oxidative protein folding studies 
with RNase A.41 Terminology used to describe the covalent structure of disulfide  
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Figure 10. Generic folding pathways for oxidative folding of a typical disulfide 
containing protein as proposed by Scheraga et al., 2000.41 
 
intermediates is as follows: A disulfide species refers to a protein with a specific pairing 
of cysteines in its disulfide bonds, whereas a disulfide ensemble is any collection of 
disulfide species. A des species is where the protein is missing only one native disulfide 
bond, for example, the des[65-72] species of RNase A has three native disulfide bonds, 
but lacks the 65-72 disulfide bond. The intermediates in the pathways are classified into 
two groups, "unstructured precursor" where the protein has random disulfide bonds, and 
"des species". It was assumed that only intermediates which have native-like structure, 
such as des species are capable of folding to a native like structure (indicated by "N" 
subscript). The "U" and "lu" subscripts represent that the corresponding species are 
unfolded or locally unfolded, respectively. 
  21 
 
Pathway I is the simplest oxidative folding pathway, as it has no structured 
intermediates. The native protein N regenerates directly from an unfolded precursor desU. 
In pathway II, folded intermediate desN is formed and is not metastable; desN then is 
oxidized directly to the native state. Pathway III involves the formation of a folded 
intermediate desN which is metastable; desN preferentially oxidizes to the native protein. 
The metastable intermediate must first undergo a local unfolding step deslu before 
oxidizing to the native state. Pathway IV involves the formation of a folded metastable 
species desN which preferentially reshuffles rather than being oxidized to the native 
protein. Pathway IV is referred to a metastable dead end pathway. The rate determining 
steps for pathways I and II are the formation of the structured species, while that for 
pathway IV is the conformational unfolding of the metastable species. Pathway III is 
intermediate between pathway II and IV; the rate determining step may be either the 
formation of the structured intermediate or the local unfolding of the structured 
intermediate, depending on the folding conditions.  
1.3.5 Hen egg white lysozyme (HEWL) 
1.3.5.1 General information 
Lysozyme, an enzyme present in tears, mucus, other body secretions, and egg 
whites, catalyzes the hydrolysis of the β (1-4) glycosidic linkage between N-
acetylmuramic acid (NAM) and N-acetylglucosamine (NAG).1 Lysozyme functions as a 
bactericidal agent or helps to dispose the bacteria after they have been killed by other 
means.1 Lysozyme has been widely studied and is one of the most mechanistically well 
characterized enzymes. In 1922, Alexander Fleming discovered lysozyme by accident in 
his laboratory. Nasal mucus was dripped into a Petri dish with bacterial cultures by 
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accident, and cells were lysed. He carefully observed this phenomenon and determined 
the substance responsible for the lysis of the bacteria. Fleming discovered that the 
antibacterial substance was an enzyme and he named it lysozyme, lyso- means capacity 
to lyse bacteria and zyme- as it is an enzyme. The X-ray structure of HEWL was 
elucidated by David Phillips in 1965. The three dimensional structure revealed that 
lysozyme is roughly ellipsoidal in shape with the dimensions of 30 x 30 x 45 Å.  
                                                  
 
 
Figure 11. Rasmol representation of native hen egg white lysozyme.42 (PDB id: 3A8Z) 
 
 
Lysozyme is a monomeric protein of 14.6 kDa containing 129 amino acids and 
eight cysteine residues forming four disulfide bonds. The four disulfide bonds occur 
between residues Cys6-Cys127, Cys30-Cys115, Cys64-Cys80, and Cys76-Cys94 and 
provide stability to the native structure of lysozyme.42 The disulfide bonds in native 
lysozyme are denoted as [6-127], [30-115], [64-80], and [76-94]. Lysozyme is made up 
of two domains, one consisting of four α-helices and a C-terminal 310 helix (called the α-
domain), and one consisting of a triple-stranded antiparallel β-sheet, a 310 helix, and a 
Cys76-Cys94 
Cys64-Cys80 
Cys30-Cys115 
Cys6-Cys127 
310 helix
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long loop (called as the β-domain).83 Additionally, a short double stranded antiparallel β-
sheet and one of the four disulfide bonds [76-94] link the two domains.83 Two disulfide 
bonds [6-127] and [30-115] are present within the α-domain, and the remaining disulfide 
bond [64-80] is located within the β-domain (Figure 11).42 
1.3.5.2 Distributions of conformers during lysozyme folding 
Identification of intermediates formed during oxidative folding provides information 
about the distributions of disulfide species as folding progress.84 As the number of 
cysteine residues increases in a protein, the probability of forming incorrect disulfide 
bonds increases. The folding of lysozyme can occur in various steps, each of which 
involves oxidation of thiols and thiol/disulfide interchange reactions (Figure 12).85 In the 
first oxidation step, species with one disulfide bond and six thiol groups are formed. 
There is the possibility of 28 such species, but only four of them have a native disulfide 
bond. In the second step, intermediates containing two disulfide bonds and four thiol 
groups are formed. Of the 210 possible two disulfide bond containing intermediates, only 
six have both disulfide bonds correctly paired. In the third step, intermediates with three 
disulfide bonds and two thiol groups are formed. Of the 420 possible structures, only four 
have native sets of disulfide bonds. In the fully oxidized state, there are four disulfide 
bonds, and of the 105 possible isomeric forms, only one has a native set of disulfide 
pairing. On the other hand, when we consider mixed protein-GSH disulfide bonds, the 
total number of possible intermediates increases to over 7000. However, during the later 
stages of folding, only a small fraction of possible three- and four-disulfide intermediates 
accumulate to significant levels. In fact, only 3 three-disulfide bonds containing 
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intermediates with native disulfide bonds, and 1 four-disulfide bonded species, the native 
protein, have been identified.42 
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Figure 12. Schematic diagram of possible disulfide intermediates during the folding of 
reduced lysozyme.85 
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1.3.5.3 Refolding kinetics of the three-disulfide intermediates 
Dobson et al. described the oxidative folding of lysozyme in terms of the disulfide 
bonded intermediates that accumulated. An acid quenched method along with reverse 
phase HPLC at pH 2.0 was used to separate the intermediates.42 The oxidative protein 
folding was carried out at pH 8.5. The elution profile showed that native-like three- 
disulfide species occurred during the later stages of folding. The most abundant 
intermediate was des [76-94], a highly native-like species, which has three native 
disulfide bonds but lacks the Cys76-Cys94 disulfide bond. Two minor intermediates were 
also observed, des [6-127] and des [64-80], which have native-like structure and three- 
native disulfide bonds.86 Figure 13 illustrates the disappearance of the fully reduced 
protein (R) and the appearance of the three-disulfide intermediates and native protein 
(N).42 The results revealed that des [76-94] was the most abundant folding intermediate 
and accounted for 40% of the total protein at one stage. Later in folding, des [76-94] and 
native protein were the only species populated at significant levels. Although des [76-94] 
has a highly native-like structure with essentially native optical properties, its enzymatic 
activity is significantly lower (50 ± 5%) than that for native protein.86 Furthermore, they 
observed two other three-disulfide intermediates, des [64-80] and des [6-127]. Des [64-
80] accumulated to lower levels (10-15%) and oxidized more quickly than des [76-94], 
whereas des [6-127] was present at even lower levels ( 5%). Since des [76-94] dominated 
the later stages of the folding reaction, it was suggested that the conversion of des [76-94] 
to native protein is likely the rate limiting step in the folding of the majority of lysozyme 
molecules. However, the kinetic profile of des [76-94] revealed that its conversion to 
native protein is a very slow process with a time constant of several hours and consistent 
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Figure 13. Schematic diagram of the oxidative refolding of lysozyme, showing the 
statistical nature and observed kinetics of protein folding. R represents fully reduced 
protein, I corresponds to ensemble of early unstructured intermediates, "N" indicates 
native-like three-disulfide intermediates, and N represents fully native protein. Figure 
from Van den Berg, B. et al, 1999.42 
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with the slow phase in the recovery of the enzymatic activity. Thus, it cannot account for 
the presence of ~35% native protein after only 60 min of folding and clearly indicates 
that ~25-30% of lysozyme molecules do not form the native state via des [76-94]. These 
~25-30% of lysozyme molecules could fold via the minor intermediates des [6-127] and 
des [64-80], which are converted more rapidly to native protein than des [76-94]. 
Therefore, des [76-94] appears to act as a kinetic trap.  
To support the hypothesis that des [76-94] is a kinetic trap, Dobson et al. carried 
out the refolding of purified des [76-94] to native protein at pH 8.5 in refolding buffers 
containing 1 or 4 M urea.42 They found that des [76-94] was converted to native protein 3 
times faster in 4 M urea than in 1 M urea and the results suggested that des [76-94] 
needed to unfold in order to form the final Cys76-Cys94 disulfide bond and generate 
native protein. Additionally, in another experiment at pH 7.4, des [76-94] was allowed to 
refold in the presence or absence of PDI, buffer containing 1 M urea, and 2 mM/0.4 mM 
GSH/GSSG. They found that the refolding rate of des [76-94] to native protein was ~8 
times faster in the presence of PDI than in the absence of PDI. Furthermore, the data for 
mutant human lysozyme also suggested that the thiol group of Cys76 in des [76-94] is 
solvent exposed, whereas that of Cys94 is buried and not accessible to GSSG or a protein 
disulfide.87,88 The fact that Cys76 is solvent exposed and Cys94 is buried in des [76-94] 
may be the reason for the slow conversion of des [76-94] to fully native state in the 
absence of PDI or high concentrations of urea.86  
 
 
 
  28 
 
1.3.6 Bovine pancreatic trypsin inhibitor (BPTI) 
1.3.6.1 General information 
 
 
 
 
Figure 14. Rasmol representation of bovine pancreatic trypsin inhibitor.89 (PDB id: 
1PIT) 
 
 
 To understand the oxidative folding pathways of disulfide containing proteins 
BPTI has been used extensively as a textbook example. BPTI is a monomeric polypeptide 
containing 58 amino acid residues, and its native state has two α-helices and two 
antiparallel β-sheets. Three disulfide bonds between cysteine residues 14-38, 30-51, and 
5-55 stabilize the native state of BPTI (Figure 14).  
The protein unfolds when the three disulfide bonds in BPTI are reduced. The 
reduced protein can then be refolded by treating it with an oxidizing agent. Various 
folding studies of BPTI has been carried out using oxidized glutathione and reduced 
glutathione or oxidized and reduced DTT.40,91 During folding of BPTI, the intermediates 
formed can be trapped and isolated. The folding pathway of BPTI is described by the 
formation of several one-disulfide and two-disulfide intermediates.92 The one- disulfide 
Cys14-Cys38 
Cys5-Cys55 
Cys30-Cys51 
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intermediate having a disulfide bond between cysteine 30 and cysteine 51 is denoted as 
[30-51] and is a native-like intermediate. Other one-disulfide intermediates seen during 
folding are [14-38] and [5-55]. Several two disulfide bond containing intermediates are 
also detected during folding [30-51;14-38], [5-55;14-38], and [30-51; 5-55] (Figure 15).90 
Some intermediates with disulfide bonds that are not contained in native protein are also 
detected during the folding process, and these intermediates are called non-native 
intermediates. for e.g. [30-51; 5-14] and [30-51; 5-38]. 
a)               b)   
                                c)        
 
Figure 15. Folding pathway of BPTI with a) one disulfide intermediate, b) two disulfide 
intermediate, and c) native protein. Figure from Bulaj, G. et al., 2001.90 
 
1.3.6.2 Folding pathway of BPTI as proposed by Kim et al.40 
The oxidative folding pathway of BPTI is well characterized and has been studied for 
four decades by various research groups.40,93-97 The pathway has been described by the 
[30-51; 5-55; 14-38] 
[30-51] [30-51; 5-55] 
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disulfide bonded intermediates that are formed during the oxidative folding.40,93,98-100 Kim 
et al. proposed the folding pathway of BPTI by trapping intermediates with acid (Figure 
16).40 Only six well populated disulfide species were seen and none of them contained 
non-native disulfide bonds. Reduced BPTI denoted by R is oxidized rapidly to one-
disulfide intermediate [30-51] or [5-55]. Both intermediates are thought to have native-
like structure. The thiols of cysteine 14 and cysteine 38 are solvent exposed in these one- 
R
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Figure 16. Schematic representation of folding pathway of BPTI, where N is native 
protein and R is reduced protein as represented by Kim et al.40 
 
disulfide intermediates and can form the 14-38 disulfide bond readily to give [30-51; 14-
38], N', and [5-55; 14-38], N*. Both N' and N* possess native-like structure and serve as 
kinetic traps for folding. The N* is very stable and does not undergo further 
rearrangement, whereas N' does rearrange slowly to form either [30-51; 5-55], NSH, or 
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N*. NSH can then rapidly oxidized to native protein (N). Under suitable oxidizing 
conditions, half of the molecules form native BPTI via N', called the productive pathway, 
while the other half are kinetically trapped in the form of N*, called the non-productive 
pathway. The free thiols in N* are buried and inaccessible to oxidizing agents and thus                        
N* is kinetically stable. 
1.4 Oxidative protein folding  
1.4.1 In vitro protein folding 
Industrially, the formation of inclusion bodies or aggregates is a serious problem 
for the production of disulfide containing proteins by recombinant DNA technology. In 
general, the lowest yielding step in the recovery of native protein from the aggregates is 
in vitro protein folding.101,41 The yield of in vitro protein folding is affected by many 
factors, such as composition of the redox buffer, the presence of folding aids, and the pH 
of the folding solution.41,101,102 Furthermore, it has been observed that the refolding yield 
decreases with an increase in the concentration of the protein.103,59 It has been shown that 
two types of interactions, intermolecular and intramolecular, compete during the 
refolding process. The intermolecular interaction is the cause for the decrease in yield as 
a function of the protein concentration.59,104 The intramolecular interaction is a 
unimolecular process, and the rate of formation of renatured protein is independent of the 
protein concentration. Conversely, the intermolecular interaction is a second or higher 
order process, and as a result, the rate of aggregation increases with protein 
concentration. One of the ways to improve the refolding yield is to suppress the 
formation of aggregates. A simple method is to carry out protein refolding at very dilute 
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concentrations (e.g. <0.1 mg/mL). However, large volumes of refolding solution are 
needed to carry out the refolding process, thereby increasing the production cost and 
time.  
1.4.1.1 Folding aids 
To date, a number of methods have been proposed to increase the refolding yield 
at moderate to high protein concentrations. One efficient strategy is the addition of 
folding aids. The most commonly used folding aids are guanidine hydrochloride, urea, 
arginine, and glycerol.18,27,105-109 Other additives include detergent and surfactants, 
polyethylene glycol, molecular chaperones, artificial chaperones, and several simple 
compounds, such as acetone, acetamide, sarcosine, and thiourea.106,110-115 Folding aids are 
proposed to increase the refolding yield by interfering with the intermolecular 
hydrophobic interactions. However, folding aids generally decrease the rate of folding.105-
107 Moreover, folding aids must be optimized for each protein, as folding aids have 
different effect on different proteins.  
1.4.1.2 Redox buffer 
 Another technique to improve the yield of renatured protein in in vitro protein 
folding is the use of a redox buffer. A redox buffer is composed of a small molecule 
disulfide and/or a small molecule thiol.5,32,116 The most commonly used redox buffer 
contains oxidized glutathione (GSSG) and reduced glutathione (GSH). Numerous studies 
have been carried out using aliphatic thiol based redox buffers to fold inclusion bodies. 
Extensively studied aliphatic thiol based redox buffers include GSH (pKa= 8.7), 
dithiothreitol (DTT) (pKa= 9.2), and β-mercaptoethanol (pKa= 9.6). However, aliphatic 
thiol based redox buffers have low folding rates below pH 7.5, as very little (less than 
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3%) of the aliphatic thiol is in the reactive thiolate form (pKa approximately 9). Recently, 
improved redox buffers have been used, such as aliphatic dithiols, synthetic peptides, and 
aromatic monothiols.32,34-38,116 Aliphatic dithiols, e.g. [(±)-trans-1,2-bis(2-mercapto-
actamido) cyclohexane (BMC)] with a thiol pKa of 8.3, and synthetic peptides can 
increase the overall yield. Raines et al. illustrated that the BMC increased the yield of 
native RNase A by two fold relative to its monothiol analog, N-methylmercaptoacetamide 
(NMA). The increase in yield was because of the presence of a second thiol group in 
BMC versus a single thiol group in NMA. Furthermore, Raines et al. showed that 
addition of BMC to S. cerevisiae growth medium increased the heterologous production 
of Schizosaccharomyces pombe acid phosphatase. However, BMC and synthetic peptides 
do not change the folding rate constant. Moreover, dithiols with a second thiol group 
have an advantage over monothiols (Figure 17). When dithiols or monothiols react with a 
protein disulfide bond, they produce a mixed disulfide bond. With the dithiols, but not 
monothiols, the second thiol group acts as a clock and provides a set amount of time for 
the protein to rearrange. If the protein does not rearrange, then the second thiol of the 
dithiol makes an intramolecular attack and disrupts the mixed disulfide bond. In the case 
of monothiols, there is no second thiol to act as a clock and the mixed disulfide can 
become kinetically trapped, and thus the overall yield of native protein decreases. 
 Furthermore, in previous studies by our group, it has been shown that aromatic 
monothiols (pKa 5.5-6.6) increased the folding rate and the overall yield of native protein 
compared to standard aliphatic thiols (pKa 8.5-10). With aromatic monothiols, the folding 
rate of ribonuclease A was 10-23 times faster than with glutathione at pH 6.0, 7-12 times 
faster at pH 7.0, and 5-8 times faster at pH 7.70.4,35,117 Additionally, it was also 
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Figure 17. a) Thiol/disulfide interchange reaction with dithiols, such as PDI, showing 
escape mechanism.32 b) Thiol/disulfide interchange reaction with monothiol showing 
kinetic trap, as a mixed disulfide between monothiol and protein substrate.  
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demonstrated that at a high protein concentration (1 mg/mL of lysozyme), aromatic 
monothiols, 4-mercaptobenzylphosphonic acid (2) and quaternary ammonium salt (3) 
(pKa 5.5-6), increased the folding rate and yield of lysozyme by 11 times and 20-40%, 
respectively, at pH 7, and by 7 times and 25%, respectively, at pH 8 in comparison with 
glutathione (pKa 8.7).38 By combining the advantageous properties of aromatic 
monothiols and aliphatic dithiols, I proposed to design aromatic dithiols which will 
increase the protein folding rate and overall yield of native protein. 
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Chapter 2 
 Specific Aims 
Most pharmaceutically relevant proteins and many extracellular proteins contain 
disulfide bonds.4 Disulfide bonds between the correct cysteine residues are essential for 
the stability and activity of almost all disulfide-containing proteins. Because of progress 
in the field of biotechnology, proteins can now be overexpressed in bacterial cells. 
During overexpression, bacteria produce large quantities of high value protein in a rapid 
and inexpensive way. However, overexpressed proteins, especially disulfide-containing 
ones, are frequently deposited as insoluble aggregates inside the bacterium, called 
inclusion bodies.101 The protein within the aggregates is inactive and non-native. To 
obtain native protein, it is necessary to isolate and resolubilize the aggregates, and then 
fold the resulting protein in vitro.16 The formation of the correct disulfide bonds during in 
vitro protein folding is the slowest. In vitro protein folding is aided by the addition of a 
redox buffer, which is composed of a small molecule disulfide and/or a small molecule 
thiol.5 The most commonly used redox buffer contains reduced glutathione (GSH) and 
oxidized glutathione (GSSG). Many in vitro protein folding studies have been carried out 
using aliphatic thiol based redox buffers. Examples of aliphatic thiol based redox buffers 
include dithiothreitol (pKa 9.2), glutathione (pKa 8.7), β-mercaptoethanol (pKa 9.6), and 
cysteine (pKa 8.3). Recently, more improved redox buffers have been employed, such as 
aliphatic dithiols, synthetic peptides, and some aromatic monothiols. Aliphatic dithiols, 
e.g., (±)-trans-1,2-bis(2-mercapto-actamido)cyclohexane (BMC) and synthetic peptides 
have been shown to improve the overall yield of native protein as compared to standard 
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aliphatic thiols (pKa 8.5 - 10) such as glutathione.32 Dithiols were designed on the basis 
of the in vivo protein folding catalyst, protein disulfide isomerase (PDI), which has two 
thiols in each active site. Furthermore, aromatic monothiols (pKa 5.5 - 6.6) have been 
demonstrated to increase the folding rate of lysozyme and RNase A in comparison with 
traditionally used aliphatic thiols such as glutathione.4 By combining the beneficial 
properties of aliphatic dithiols and aromatic monothiols, I propose to design aromatic 
dithiols that will increase the in vitro protein folding rates and overall yields of the 
disulfide containing proteins. 
1) To synthesize the following aromatic monothiols and their disulfides on a multigram 
scale for the folding of lysozyme and bovine pancreatic trypsin inhibitor. 
COOH
SH SH
P
HO
HO O
SH
N
Br
S OO
OH
SH
1 2 3 4  
COOH
S S
P
HO
HO O
S
N
Br
S OO
O Na
S
2 2 2 2
5 6 7 8  
 
2) To synthesize two series of aromatic ethylene glycol dithiols and determine their 
ability to enhance the in vitro folding rates and yields of lysozyme. 
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SH
OO
O
SHm
m = 1, 2, 3
SH
O
O
SH
O
m
m = 0, 1, 2, 3
9, 10, 11, 12 13, 14, 15  
3) To synthesize aromatic quaternary ammonium salt dithiols and use them for the 
folding of lysozyme at high protein concentration (1 mg/mL). 
 
                                             
SH
N N
SH
BrBr
m = 1,4
m
16, 17  
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Chapter 3 
Materials and general methods 
Hen egg white lysozyme was purchased from Roche Applied Sciences and used 
without further purification. Bis tris propane, Tris, sodium ethylenediaminetetraacetate 
(EDTA), dithiothreitol (DTT), Micrococcus lsyodeikticus, guanidine hydrochloride (Gdn 
HCl), and the reduced and oxidized forms of glutathione (GSH and GSSG, respectively) 
were purchased from Sigma. Sephadex G-25 was purchased from GE Healthcare. The 
reagents used to synthesize ortho-substituted aromatic mono-, di-, tri-, and tetraethylene 
glycol dithiols (9, 10, 11, and 12) and para-substituted aromatic di-, tri-, and 
tetraethylene glycol dithiols (13, 14, and 15) were purchased from Aldrich. The p-
mercaptobenzoic acid (1) and its disulfide (5) were synthesized as described 
previously.43,118 1H NMR spectra were referenced to TMS at 0.00 ppm. 13C NMR spectra 
were referenced to 77.00 ppm (CDCl3) or 49.00 ppm (CD3OD). Elemental analyses were 
performed by Galbraith Laboratories, Inc., Knoxville, TN. High resolution mass 
spectroscopy (HRMS) was conducted by Florida State University, Tallahassee, FL. 
3.1 Synthesis of aromatic monothiols and their corresponding disulfides (1-8) 
3.1.1 Synthesis of 4-mercaptobenzoic acid (1)43,119         
3.1.1.1 Synthesis of methyl 4-(dimethylcarbamothioyloxy)benzoate (20)   
CO2CH3
OH
DABCO, DMF
Cl N
S
CO2CH3
O N
S
95%
18 20
19
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Methyl 4-hydroxybenzoate (18) (38.75 g, 0.254 mol) and 1,4-diazabicylco [2.2.2] 
octane (DABCO) (80.0 g, 0.713 mol) were dissolved in 300 mL of DMF. After all of the 
solid had been dissolved, N,N-dimethylthiocarbamoylchloride (19) (42.0 g, 0.339 mol) 
was added to the solution. The solution was stirred for 1.5 h at 65 oC. The reaction 
mixture was then poured onto crushed ice and acidified to pH 3 with 6.0 N HCl. The 
white precipitate that formed was filtered and recrystallized from ethanol to provide 
57.43 g of methyl 4-(dimethylcarbamothioyloxy)benzoate (20), 95% yield.  
1H NMR (CDCl3, 400 MHz) δ 8.08 (d, J = 8.7 Hz, 2H), 7.14 (d, J = 8.7 Hz, 2H), 3.91 (s, 
3H), 3.45 (s, 3H), 3.35 (s, 3H). 
3.1.1.2 Synthesis of methyl 4-(dimethylcarbamoylthio)benzoate (21)  
CO2CH3
S N
O

210-240 oC
CO2CH3
O N
S
34%
20 21  
Methyl 4-(dimethylcarbamothioyloxy)benzoate (20) (23.80 g 0.099 mol) was 
added to a 500- mL round bottom flask and then heated to 210-240 oC. After 2.5 h, the 
flask was cooled to room temperature. The residue was recrystallized from cyclohexane 
and then twice from ethanol to give 8.0 g of methyl 4-(dimethylcarbamoylthio)benzoate 
(21), 34% yield. 
1H NMR (CDCl3, 400 MHz) δ 8.03 (d, J = 8.6 Hz, 2H), 7.57 (d, J = 8.6 Hz, 2H), 3.92 (s, 
3H), 3.10 (brs, 3H), 3.04 (brs, 3H). 
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3.1.1.3 Synthesis of 4-mercaptobenzoic acid (1) 
COOH
SH
NaOH, MeOH
74%
H2O, 
CO2CH3
S N
O
21 1  
Argon was bubbled through a solution of NaOH (3.61 g, 0.090 mol) in 40 mL of 
MeOH and 1 mL of H2O. After 15 min, methyl 4-(dimethylcarbamoylthio)benzoate (21) 
(7.75 g, 0.032 mol) was added to it, and the mixture was refluxed under Ar for 3 h. The 
reaction mixture was concentrated in vacuo. The residue was then poured onto crushed 
ice and acidified to pH 2 with 2.0 N HCl. The aqueous layer was extracted with ethyl 
acetate (3 x 100 mL), and the combined organic layers were then washed with brine (2 x 
100 mL), dried (MgSO4), and concentrated in vacuo. The residue was then recrystallized 
from benzene to provide 4.0 g of 4-mercaptobenzoic acid (1) as light yellow crystals, 
74% yield.  
1H NMR (CD3OD, 400 MHz) δ 7.87 (d, J = 8.5 Hz, 2H), 7.36 (d, J = 8.6 Hz, 2H). 13C 
NMR (MeOD, 100 MHz) δ 169.5, 141.0, 131.3, 128.9, 128.4. 
3.1.1.4 Synthesis of 4,4'-disulfanediyldibenzoic acid [disulfide of 4-mercaptobenzoic 
acid (5)]118 
COOH
S
I2
EtOH
86%
COOH
SH
2
1 5  
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The 4-mercaptobenzoic acid (1) (1.25 g, 8.11 mmol) was dissolved in ethanol, 
and a saturated solution of I2 in 95% ethanol was slowly added to it. The progress of the 
reaction was monitored by the disappearance of the brown color of iodine. The saturated 
solution of iodine was continuously added until a light yellow color persisted. The off 
white precipitate was filtered and washed with ethanol. The precipitate was dried with 
benzene under reduced pressure to remove any adsorbed iodine and ethanol to give 1.07 
g of product (5), 86% yield.  
1H NMR (DMSO, 400 MHz) δ 7.93 (d, J = 8.5 Hz, 4H), δ 7.63 (d, J = 8.2 Hz, 4H); 13C 
NMR (DMSO, 100 MHz) δ 166.6, 140.7, 130.2, 129.7, 126.1. 
3.1.2 Synthesis of 4-mercaptobenzylphosphonic acid (2) 
3.1.2.1 Synthesis of S-p-tolyl benzothioate (24)120,121 
CH3
SH
NEt3/toulene
CH3
S
Ph
OClO
78%
22 23 24  
To toluene (2 L), p-toluenethiol (22) (51.20 g, 0.412 mol) and benzoyl chloride 
(23) (58.65 g, 0.420 mol) were added. The solution was cooled to 0 oC, and triethylamine 
(40.77 g, 0.402 mol) was added slowly with stirring for 1 h. The reaction mixture was 
stirred for an additional 1 h, filtered, and the solid washed with toluene. The fitrate was 
then washed with water, dried (MgSO4), filtered, and concentrated in vacuo. The crude 
was recrystallized from ethanol to provide 73.58 g of S-p-tolyl benzothioate (24), 78% 
yield.  1H NMR (CDCl3, 400 MHz) δ 8.01 (d, J = 7.4 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H), 
7.48 (t, J = 7.9 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 7.26 (d, J = 8.3 Hz, 2H), 2.40 (s, 3H). 
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3.1.2.2 Synthesis of S-4-(bromomethyl)phenyl benzothioate (25)120 
NBS, h
S
Ph
O
Br
CH3
S
Ph
O
69%
24 25  
To deoxygenated benzene (170 mL), S-p-tolyl benzothioate (24) (27.31 g, 0.120 
mol) and N-bromosuccinimide (21.39 g, 0.120 mol) were added. The reaction mixture 
was then irradiated with a 250W GE heat lamp, providing sufficient energy to initiate 
reflux. After 30 min at reflux, the solution was cooled to 0 oC, filtered, and concentrated 
in vacuo. The residue was then partitioned between 800 mL of CH2Cl2 and 400 mL of 
water. The aqueous layer was washed with 200 mL of CH2Cl2. The organic layers were 
combined, dried (MgSO4), filtered, and concentrated in vacuo. The solid was then 
recrystallized from hexanes to provide 25.09 g of product, approximate 69% yield, as a 
24:1 mixture of S-4-(bromomethyl)phenyl benzothioate (25) and S-4-
(dibromomethyl)phenyl benzothioate.  
1H NMR (CDCl3, 400 MHz) δ 8.01 (d, J = 8.8 Hz, 2H), 7.62 (t, J = 7.4 Hz, 1H), 7.52 -
7.47 (m, 6H), 4.52 (s, 2H). 
3.1.2.3 Synthesis of S-4-((diethoxyphosphoryl)methyl)phenyl benzothioate (26)122 
Triethylphosphite (34.49 g, 0.207 mol) was added to the 24:1 mixture of S-(4-
bromomethyl)phenyl benzenecarbothioic acid (25) and S-(4-dibromomethyl)phenyl 
benzenecarbothioic acid (24.48 g, 0.079 mol). The reaction mixture was then stirred at 
105 oC under a flow of Ar. After 90 min of stirring, the reaction mixture was cooled to -5 
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oC in the freezer to give crystals. The crystals were washed with hexanes and then 
recrystallized from hexanes: CH2Cl2 (95:5) to provide 19.96 g of S-4-
((diethoxyphosphoryl)methyl)phenyl benzothioate (26), 69% yield.  
S
Ph
O
P
EtO
EtO O
P(OEt)3
105 oC
69%S
Ph
O
Br
25 26  
1H NMR (CDCl3, 400 MHz) δ 8.01 (d, J = 7.3 Hz, 2H), 7.60 (t, J = 7.4 Hz, 1H), 7.50 - 
7.45 (m, 4H), 7.39 (dd, J = 8.3, 2.3 Hz, 2H), 4.04 (quintet, J = 7.3 Hz, 4H), 3.20 (d, J = 
21.8 Hz, 2H), 1.26 (t, J = 7.1 Hz, 6H). 
3.1.2.4 Synthesis of S-4-((diethoxyphosphoryl)methyl)phenyl ethanethioate (27)   
1) NaOEt/EtOH
S O
P
EtO
EtO O
94%
2) Ac2O
S
Ph
O
P
EtO
EtO O
26 27  
Sodium hydride (7.47 g of 60 wt%, 0.186 mol) was added to ethanol (1150 mL) 
and the solution was deoxygenated by bubbling Ar through it for 45 min. S-4-
((diethoxyphosphoryl)methyl)phenyl benzothioate (26) (19.96 g, 0.054 mol) was added 
to the solution, and after 25 min the reaction was quenched by adding acetic anhydride 
(56.68 g, 0.55 mol). Absence of thiol groups were detected by a negative Ellman’s test. 
The solution was reduced under pressure and the slurry was partitioned between 1400 mL 
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of CH2Cl2 and 700 mL of sat. aq. sodium bicarbonate. The water layer was washed with 
an additional 700 mL of CH2Cl2. The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo. The crude material was subjected to flash 
chromatography (1:1 hexanes/ethyl acetate to pure ethyl acetate) to provide 15.29 g of S-
4-((diethoxyphosphoryl)methyl)phenyl ethanethioate (27) as an oil, 94% yield. 1H NMR 
(CDCl3, 400 MHz) δ 7.35 (s, 4H), 4.02 (quintet, J = 7.2 Hz, 4H), 3.16 (d, J = 21.8 Hz, 
2H), 2.40 (s, 3H), 1.24 (t, J = 7.1 Hz, 6H). 
3.1.2.5 Synthesis of 4-mercaptobenzylphosphonic acid (2)122  
SH
P
HO
HO O
HCl,
78%

S O
P
EtO
EtO O
27 2  
The S-4-((diethoxyphosphoryl)methyl)phenyl ethanethioate (27) (3.05 g, 0.0100 
mol) was added to conc HCl (500 mL) and heated at 130 oC for 5 h. The reaction mixture 
was reduced to approximately 100 mL by concentrating in vacuo, filtered, and cooled to 
0 oC. The solution was filtered, and the solid was washed with water. The solid was then 
lyophilized to provide 1.58 g of 4-mercaptobenzylphosphonic acid (2), 78% yield.  
1H NMR (CD3OD, 400 MHz) δ 7.22 - 7.16 (m, 4H), 3.05 (d, J  = 21.6 Hz, 2H); 13C NMR 
(CD3OD, 100 MHz) δ 131.6, (d, J = 6 Hz), 131.5, 131.1 (d, J = 4 Hz), 130.1 (d, J = 3 
Hz), 35.2 (d, J = 135 Hz). 
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3.1.2.6 Synthesis of 4,4'-disulfanediylbis(4,1-phenylene)bis(methylene)diphosphonic 
acid [disulfide of 4-mercaptobenzylphosphonic acid (6)]38 
 
O2
S
P
HO
HO O
83%
SH
P
HO
HO O
2
2 6  
The 4-mercaptobenzylphosphonic acid (2) (0.506 g, 2.50 mmol) was dissolved in 
30 mL of water, and the resulting mixture was stirred vigorously under air. After 1 week, 
the mixture was filtered by suction filtration to provide 0.417 g of 4,4'-
disulfanediylbis(4,1-phenylene)bis(methylene)diphosphonic acid (6) as a white solid, 
83% yield.  
1H NMR (DMSO, 400 MHz) δ 7.44 (d, J = 7.8 Hz, 4H), 7.25 (d, J = 6.8 Hz, 4H), 2.94 
(d, J = 21.5 Hz, 4H); 13C NMR (DMSO, 100 MHz) δ 134.2 (d, J = 9 Hz), 133.2 (d, J = 3 
Hz), 130.8 (d, J = 6 Hz), 127.5 (d, J = 2 Hz), 34.9 (d, J = 131 Hz). 
3.1.3 Synthesis of quaternary ammonium thiol salt (Mono QAS) (3) 
3.1.3.1 Synthesis of 1-(4-(benzoylthio)phenyl)-N,N,N-trimethylmethanaminium 
bromide [quaternary ammonium salt (28)]120 
S
Ph
O
Br
S
Ph
O
N Br
NMe3
81%
25 28  
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Trimethylamine (38.33 mL of a 33% solution in ethanol, 0.471 mol) was rapidly 
added to benzyl bromide (25) (25.0 g, 0.081 mol) at 0 oC and stirred. After 10 min, the 
mixture was concentrated in vacuo, and then the residue was recrystallized from 
EtOAc/EtOH (95:5) to give 18.85 g of the quaternary ammonium salt (28), 81% yield.  
1H NMR (CDCl3, 400 MHz) δ 7.98 (d, J = 7.2 Hz, 2H), 7.81 (d, J = 8.2 Hz, 2H), 7.63-
7.59 (m, 3H), 7.49 (t, J = 8.0 Hz, 2H), 5.21 (s, 2H), 3.42 (s, 9H). 
3.1.3.2 Synthesis of 1-(4-(mercaptophenyl)-N,N,N-trimethylmethanaminium 
bromide [Mono QAS (3)]120 
HBr
SH
N
Br
quantitative
S
Ph
O
N Br
28 3  
The quaternary ammonium salt (28) (0.93 g, 2.54 mmol) was lyophilized from 
water and then dissolved in 3 mL of HBr (48 wt.% in water) and 15 mL of water. The 
solution was refluxed for 5 h, cooled to 0 oC, filtered, extracted with 2 x 30 mL EtOAc, 
and partially concentrated. The solution was then lyophilized several times by dissolving 
the residue in water to give Mono QAS (3) in quantitative yield.  
1H NMR (CD3OD, 400 MHz) δ 7.44 (s, 4H), 4.50 (s, 2H), 3.10 (s, 9H). 
3.1.3.3 Synthesis of 1,1'-(4,4'-disulfanediylbis(4,1-phenylene)bis(N,N,N-
trimethylmethanaminium) bromide [disulfide of Mono QAS (7)]38   
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N
S
Br
SH
N
Br
O2
H2O
quantitative
2
3 7  
 Disulfide of Mono QAS (7) was prepared from Mono QAS (3). Mono QAS (3) 
was dissolved in 50 mL of water and the resulting mixture was stirred vigorously under 
air. After 6 months, the solution was lyophilized to provide disulfide of Mono QAS (7).  
1H NMR (CD3OD, 400 MHz) δ 7.68 (d, J = 8.5 Hz, 4H), 7.61 (d, J = 8.5 Hz, 4H), 4.60 
(s, 4H), 3.13 (s, 18H). 
3.1.4. Synthesis of 4-mercaptobenzene sulfonic acid (4) 
3.1.4.1 Synthesis of 4-mercaptobenzene sulfonic acid (4)123  
NH2
S OO
OH
1) NaOH
3) S8, Na2S
NH3
S OO
O
S
2
S OO
OH
S
2
S OO
OH
SH
H+
MeOH, H2O
29 30 31 4
PPh3
H3N
4)
Cl
12% overall yield
2) NaNO2, HCl
 
A solution of sodium hydroxide (20.05 g, 0.50 mol) in 500 mL of water was 
prepared, and then 4-aminobenzenesulfonic acid (29) (86.48 g, 0.50 mol) was dissolved 
in it. To the reaction mixture, 100 mL of conc HCl was added followed by gradual 
addition of a solution of sodium nitrite (34.54 g, 0.50 mol) in 100 mL of water at 1-3 oC. 
The resulting suspension was then slowly added into a solution of sodium disulfide at 1-3 
oC. The solution of sodium disulfide was prepared by co-melting sulfur (16.01 g, 0.50 
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mol) and sodium sulfide nonahydrate (120.1 g, 0.50 mol) at 65 oC, in 500 mL of water. 
The reaction mixture was warmed until the evolution of gas ceased and then returned to 
room temperature. The insoluble material was filtered off. To the filtrate, a freshly 
prepared solution of aniline (93.4 g, 1.00 mol) and conc HCl (84 mL) in 200 mL of water 
were added. The mixture was then cooled overnight. The precipitate was filtered, 
recrystallized from water, and then washed with ethanol and n-hexane to give 23.87 g 
mixture (30:70)  of a mono- and dianilinium 4,4'-dithiobis(benzenesulfonate) (30) as 
colorless crystals.  
1H NMR (DMSO, 400 MHz) δ 7.59 (d, J = 8.4 Hz, 4H), 7.48 - 7.42 (m, 6.8H), 7.31 (t, J 
= 7.4 Hz, 1.4H), 7.25 (d, J = 8.6 Hz, 2.8H). 
 The mixture of a mono- and dianilinium 4,4'-dithiobis(benzenesulfonate) (30) 
(8.70 g) was then subjected to ion-exchange column chromatography (63 mL of Dowex 
50X2-200, H-form) using methanol: water (2:1) as the eluent. The acidic fractions were 
collected and reduced under pressure to give the residue (31).  
1H NMR (CD3OD, 400 MHz) δ 7.77 (d, J = 8.5 Hz, 4H), 7.58 (d, J = 8.5 Hz, 4H).  
 The residue (31) was dissolved in 145 mL of methanol, and then 
triphenylphosphine (8.84 g, 0.033 mol) and about 1 mL of water were added. The 
reaction mixture was stirred overnight at room temperature and then evaporated in vacuo. 
The residue was dissolved in 90 mL of CH2Cl2, and the organic layer was washed with 
water. The organic layer was dried (MgSO4), filtered, reduced under pressure, and then 
the residue was dissolved in dioxane followed by filtration of insoluble materials. The 
filtrate was reduced under pressure, and the resulting oil was recrystallized from benzene 
to give 4-mercaptobenzensulfonic acid (4) (4.28 g, 12% overall yield) as yellow crystals. 
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1H NMR (CD3OD, 400 MHz) δ 7.66 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.5 Hz, 2H).  
3.1.4.2 Sodium salt of sulfonic acid disulfide (8) 
NH2
S OO
OH
S OO
O
S
2
S OO
O
S
2
Na+
H3N
Na
 overall 
yield 13%
1) NaOH
3) S8, Na2S
NH3
4)
Cl
2) NaNO2, HCl
29 30 8  
Sodium ions were exchanged with H+ ions by treating the Dowex 50wx2 H+ form 
with 0.1 M NaOH and 0.5 M NaCl in 500 mL of water. Water was run through the resin 
to make it neutral followed by methanol:water (2:1) to equilibrate the resin with 
methanol:water. The dianilinium salt (30) (5.16 g, 9.15 mmol) was then subjected to ion 
exchange resin (Na+ form) with methanol:water (2:1) as the eluent. The fractions those 
were UV active were collected and evaporated in vacuo to give the sodium salt of 
sulfonic acid disulfide (8) (3.02 g, 13% yield).  
1H NMR (DMSO, 400 MHz) δ 7.59 (d, J = 8.4 Hz, 4H), 7.46 (d, J = 8.4 Hz, 4H).  
3.2 Synthesis of ortho-and para-substituted aromatic ethylene glycol dithiols (9-15) 
3.2.1 Synthesis of di-, tri-, tetra-, and hexaethylene glycol thiols (35, 36, 43, and 44) 
3.2.1.1 Synthesis of 2-(2-mercaptoethoxy)ethanol and 2-[2-(2-
mercaptoethoxy)ethoxy]ethanol [di- and triethylene glycol thiols (35 and 36)]124 
H2N NH2
S
2) NaOH
3) HCl
HO
O
SHm
m = 1, 2
1) reflux
59%, 67%
HO
O
Clm
m = 1, 2
32 33, 34 35, 36  
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General procedure 
Thiourea (32) (3.67 g, 0.048 mol) and 2-[2-(2-chloroethoxy)ethoxy]ethanol (34) 
(5.27 g, 0.031 mol) were dissolved in 100 mL of water, and the solution was bubbled 
with argon for 30 min and then heated to reflux under argon. After 18 h, the reaction 
mixture was cooled to room temperature, and then a solution of NaOH (10.53 g, 0.263 
mol) in 50 mL of deoxygenated H2O was added to it. The reaction mixture was refluxed 
for another 3 h and then poured onto ice and adjusted to pH 4 with conc HCl under argon. 
The reaction mixture was washed with CHCl3 (3 x 100 mL). The organic layers were 
combined and then extracted with brine (2 x 100 mL), dried over MgSO4, filtered, and 
concentrated under reduced pressure to leave 3.50 g of the triethylene glycol thiol (36) as 
a colorless oil, 67% yield. 
2-(2-Mercaptoethoxy)ethanol [diethylene glycol thiol (35)]: 59% yield, 1H NMR 
(CDCl3, 400 MHz) δ 3.73 (q, J = 4.8 Hz, 2H), 3.61 (t, J = 6.3 Hz, 2H), 3.57 (t, J = 4.7 
Hz, 2H), 2.70 (dt, J = 8.2, 6.3 Hz, 2H), 2.29 (t, J = 5.8 Hz, 1H), 1.56 (t, J = 8.2 Hz, 1H).     
2-[2-(2-Mercaptoethoxy)ethoxy]ethanol [triethylene glycol thiol (36)]: 67% yield, 1H 
NMR (CDCl3, 400 MHz) δ 3.73 (t, J = 4.5 Hz, 2H), 3.69 - 3.60 (m, 8H), 2.70 (dt, J = 8.2, 
6.4 Hz, 2H), 2.42 (brs, 1H), 1.58 (t, J = 8.2 Hz, 1H).    
3.2.1.2 Synthesis of 2-[2-(2-(2-hydroxyethoxy)ethoxy)ethoxy]ethyl-4-
methylbenzenesulfonate and 17-hydroxy-3,6,9,12,15-pentaoxaheptadecyl-4-
methylbenzenesulfonate [tetra- and hexaethylene glycol monotosylate (41 and 42)]125 
General procedure 
para-Toluenesulfonyl chloride (14.25 g, 0.075 mol) was suspended in 
tetraethylene glycol (39) (29.1 g, 0.15 mol) at 0 oC, and triethylamine (18.75 mL, 0.133 
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mol) was then added drop wise to the suspension while maintaining the reaction mixture 
at 0 oC. The suspension was stirred at 0 oC for 1 h and then for 16 h at room temperature. 
 
           
O
OH
OH
p-TsCl, NEt3
     16 h
O
O
OH
Ts
m m
m = 3, 5
45%, 50%
m = 3, 5
39, 40 41, 42  
 
The resulting suspension was dissolved in 500 mL of CH2Cl2 and washed with 1 M HCl 
(2 x 125 mL) followed by 250 mL of distilled water. The organic layer was dried with 
MgSO4, filtered, and reduced under pressure to give 17.82 g of the mono- and ditosylate 
of tetraethylene glycol. The residue was then purified by flash chromatography using 
hexane/ethyl acetate (3:1, v/v)  (0:1, v/v) to give 11.23 g of tetraethylene glycol 
monotosylate (41), 45% yield . 
2-[2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy]ethyl-4-methylbenzenesulfonate  
[tetraethylene glycol monotosylate (41)]: 45% yield, 1H NMR (CDCl3, 400 MHz) δ 
7.80 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.16 (t, J = 4.8 Hz, 2H), 3.70 - 3.59 (m, 
14H) 2.54 (brs, 1H), 2.45 (s, 3H).  
2,2'-(2,2'-Oxybis(ethane-2,1-diyl)bis(oxy))bis(ethane-2,1-diyl)bis(4-
methylbenzenesulfonate [tetraethylene glycol ditosylate]: 1H NMR (CDCl3, 400 MHz) 
δ 7.77 (d, J = 8.3 Hz, 4H), 7.32 (d, J = 8.3 Hz, 4H), 4.13 (t, J = 4.8 Hz, 4H), 3.66 (t, J = 
4.8 Hz, 4H), 3.54 (m, 8H) 2.43 (s, 6H).  
17-Hydroxy-3,6,9,12,15-pentaoxaheptadecyl-4-methylbenzenesulfonate  
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[hexaethylene glycol monotosylate (42)]: 50% yield, 1H NMR (CDCl3, 400 MHz) δ 
7.79 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.2 Hz, 2H), 4.15 (t, J = 4.8 Hz, 2H), 3.71 - 3.58 (m, 
22H), 2.90 (brs, 1H), 2.45 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 144.78, 133.00, 
129.81, 127.93, 72.49, 70.67, 70.55, 70.52, 70.50, 70.49, 70.46, 70.28, 69.27, 68.62, 
61.64, 21.60. 
3.2.1.3 Synthesis of 2-[2-(2-(2-mercaptoethoxy)ethoxy)ethoxy]ethanol and 17-
mercapto-3,6,9,12,15-pentaoxaheptadecan-1-ol [tetra- and hexaethylene glycol thiol 
(43 and 44)]125 
1. Thiourea
    EtOH, 24 h O
SH
OH
2. NaOH/EtOH
    H2O, 2.5 h
m
89%, 58% m = 3, 5
O
O
OH
Ts
m
m = 3, 5
41, 42 43, 44  
 
General procedure 
Tetraethylene glycol monotosylate (41) (5.32 g, 0.015 mole) and thiourea (1.16 g, 
0.015 mole) were dissolved in 36 mL of absolute ethanol and heated to reflux under an 
argon atmosphere. After 24 h, a solution of NaOH (1.56 g, 0.039 mole) in 22 mL of 
ethanol/water (9:1 v/v) was added and then the solution was reflux under an argon 
atmosphere for another 2.5 h. Subsequently, the reaction mixture was cooled down to 
room temperature and then acidified to pH 2 with conc HCl. The acidic solution was 
reduced under pressure, and then the residue was dissolved in 64 mL of ethyl 
acetate/ethanol mixture (5:1, v/v) and heated for 5 min at 50 oC before filtering. The 
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crude product was purified by flash chromatography using ethyl acetate/ethanol (10:1, 
v/v) giving 2.84 g of a tetraethylene glycol thiol (43) as yellow oil, 89% yield. 
2-[2-(2-(2-Mercaptoethoxy)ethoxy)ethoxy]ethanol [tetraethylene glycol thiol (43)]: 
89% yield, 1H NMR (CDCl3, 400 MHz) δ 3.70 - 3.58 (m, 14H), 2.68 (dt, J = 8.1, 6.4 Hz, 
2H), 1.61 (t, J = 8.2 Hz, 1H).    
17-Mercapto-3,6,9,12,15-pentaoxaheptadecan-1-ol [hexaethylene glycol thiol (44)]: 
58% yield, 1H NMR (CDCl3, 400 MHz) δ 3.67 - 3.54 (m, 22H), 2.65 (t, J = 4.8 Hz, 2H); 
13C NMR (CDCl3, 100 MHz) δ 74.13, 73.72, 71.63, 71.62, 71.60, 71.58, 71.57, 71.45, 
71.21, 62.28, 24.76. 
3.2.2 Synthesis of di-, tri-, tetra-, and hexaethylene glycol disulfides (37, 38, 45, and 
46) 
HO
O
SHm
H2O, Et3N
m = 1, 2, 3, 5 m = 1, 2, 3, 5
45%, 84%,91%, 95%
35, 36, 43, 44 37, 38, 45, 46
HO
O
Sm 2
 
General procedure 
Triethylamine (0.5 mL, 3.58 mmol) was added to a solution of 2-[2-(2-
mercaptoethoxy) ethoxy]ethanol (triethylene glycol thiol) (36) (3.5 g, 21.08 mmol) in 25 
mL of distilled water. The solution was stirred vigorously for 1 week under air. The 
reaction mixture was brought to pH 4 with conc HCl, and the aqueous layer was then 
extracted with CHCl3 (3 x 25 mL). The organic layers were combined and washed with 
brine (2 x 25 mL), dried over MgSO4, filtered, and reduced under pressure to give 2.93 g 
of triethylene glycol disulfide (38) as a yellow oil, 84% yield. 
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2,2'-(2,2'-Disulfanediylbis(ethane-2,1-diyl)bis)oxy))diethanol [diethylene glycol 
disulfide (37)]: 45% yield, 1H NMR (CDCl3, 400 MHz) δ 3.78 - 3.73 (m, 8H), 3.60 (t, J 
= 4.4 Hz, 4H), 2.94 (t, J = 6.3 Hz, 4H), 2.61 (t, J = 6.2 Hz, 2H). 
3,6,13,16-Tetraoxa-9,10-dithiaoctadecane-1,18-diol [triethylene glycol disulfide 
(38)]: 84% yield, 1H NMR (CDCl3, 400 MHz) δ 3.75 - 3.70 (m, 8H), 3.66 - 3.63 (m, 8H), 
3.59 (t, J = 4.5 Hz, 4H), 3.04 (t, J = 5.5 Hz, 2H) 2.90 (t, J = 6.6 Hz, 4H); 13C NMR 
(CDCl3, 100 MHz) δ 72.6, 70.4, 70.3, 69.6, 61.7, 38.4. 
3,6,9,16,19,22-Hexaoxa-12,13-dithiatetracosane-1,24-diol [tetraethylene glycol 
disulfide (45)]: 91% yield, 1H NMR (CDCl3, 400 MHz) δ 3.72 (t, J = 6.7 Hz, 4H), 3.68 - 
3.63 (m, 20H), 3.60 (t, J = 4.5 Hz, 4H), 2.89 (t, J = 6.7 Hz, 4H), 2.74 (t, J = 5.7 Hz, 2H); 
13C NMR (CDCl3, 100 MHz) δ 72.4, 70.4, 70.3, 70.1, 69.4, 61.4, 38.2. 
3,6,9,12,15,22,25,28,31,34-Decaoxa-18,19-dithiahexatriacontane-1,36-diol 
[hexaethylene glycol disulfide (46)]: 95% yield, 1H NMR (CDCl3, 400 MHz) δ 3.68 - 
3.51 (m, 44H), 2.90 (brs, 2H), 2.82 (t, J = 6.7 Hz, 4H); 13C NMR (CDCl3, 100 MHz) δ 
72.7, 70.53, 70.52, 70.45, 70.44, 70.42, 70.3, 70.2, 69.5, 61.5, 38.4. 
3.2.3 Synthesis of ortho- and para-substituted aromatic ethylene glycol dithiols 
polymer126 
General procedure  
In 4 mL of THF was dissolved 4,4'-dithiobenzoic acid (5) (0.213 g, 0.696 mmol), 
and 10 µL of DMF was added to it. The solution was cooled to 0 oC, and slowly oxalyl 
chloride (48) (0.883 g, 6.96 mmol) was added into the solution via syringe. The solution 
was stirred for 3 h and then reduced under pressure to give a yellow oil. Yellow oil was 
dissolved in 6 mL of CH2Cl2 and then transferred to a flask containing triethylene glycol  
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S
2
S
2
Cl
Cl
O
O
DMF, THF
HO O Sm 2
Et3N, CH2Cl2
para, m = 1, 2, 3
S
COOH COCl O O S
m
O n
ortho, m = 0, 1, 2, 3
ortho, m = 0, 1, 2, 3
para, m = 1, 2, 3
ortho = 47
para = 5
48
ortho = 49
para = 55
para = 37, 38, 45
ortho = 50, 37, 38, 45
ortho = 51, 52, 53, 54
para = 56, 57, 58  
disulfide (38) (0.981 g, 2.98 mmol), Et3N (0.77 mL, 5.57 mmol), and 46 mL of CH2Cl2 at 
0 oC. The reaction mixture was stirred at 0 oC for 30 min and gradually warmed to room 
temperature, and then stirring continued overnight. The reaction mixture was dissolved in 
50 mL of CH2Cl2 and then washed with 50 mL of 0.1 N HCl. The organic layer was then 
washed with water (2 x 50 mL), dried (MgSO4), filtered, and reduced under pressure to 
give 0.81 g of a polymer (57). 
3.2.4 Reduction of ortho- and para-substituted aromatic ethylene glycol dithiol 
polymer with dithiothreitol (DTT) 
 
DTT, Et3N
SH
O O SHm
O
S
O O Sm
O n Overall yield
ortho - 46%,30%, 63%, 58%
para - 95%, 59%, 68% para, m = 1, 2, 3
ortho, m = 0, 1, 2, 3
para, m = 1, 2, 3
ortho, m = 0, 1, 2, 3
ortho = 51, 52, 53, 54 ortho = 9, 10, 11, 12
para = 56, 57, 58 para = 13, 14, 15  
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General procedure 
Triethylamine (0.5 mL, 3.59 mmol) and DTT (1.032 g, 6.70 mmol) were added to 
a concentrated solution of a polymer (57) (0.81 g) in 15 mL of CH2Cl2. The reaction 
mixture was stirred for 2 h and 3 h for triethylene glycol polymer and tetraethylene glycol 
polymer, respectively, under argon and then the mixture was extracted with 50 mL of 
ethyl acetate. The organic layer was washed with water (2 x 50 mL), dried over MgSO4, 
filtered, and concentrated under reduced pressure to give the crude product. The crude 
product was then purified by silica gel chromatography using CH2Cl2: hexane (2:1 for 
monoethylene glycol dithiol and diethylene glycol dithiol, 4:1 for triethylene glycol 
dithiol, and 6:1 for tetraethylene glycol dithiol) to give 0.124 g of a para-substituted 
aromatic triethylene glycol dithiol (14) as yellow oil , 59% overall yield. 
2-mercaptoethyl-2-mercaptobenzoate [ortho-substituted aromatic monoethylene 
glycol dithiol (9)]: 46 % overall yield, 1H NMR (CDCl3, 400 MHz) δ 8.04 (d, J = 7.4 Hz, 
1H), 7.33 - 7.30 (m, 2H), 7.17 (ddd, J = 8.0, 6.0, 2.5 Hz, 1H), 4.61 (s, 1H), 4.45 (t, J = 
6.6 Hz, 2H), 2.90 (dt, J = 8.5, 6.6 Hz, 2H), 1.59 (t, J = 8.6 Hz, 1H); 13C NMR (CDCl3, 
100 MHz) δ 166.4, 138.5, 132.8, 131.9, 131.1, 125.8, 124.9, 66.6, 23.5.  
2-(2-mercaptoethoxy)ethyl-2-mercaptobenzoate [ortho-substituted aromatic 
diethylene glycol dithiol (10)]: 30% overall yield, 1H NMR (CDCl3, 400 MHz) δ 8.05 
(d, J = 8.5 Hz, 1H), 7.32 - 7.30 (m, 2H), 7.16 (ddd, J = 8.1, 5.8, 2.8 Hz, 1H), 4.66 (s, 
1H), 4.48 (t, J = 4.7 Hz, 2H), 3.81 (t, J = 4.8 Hz, 2H), 3.66 (t, J = 6.3 Hz, 2H), 2.71 (dt, J 
= 8.1, 6.3 Hz, 2H), 1.60 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 166.7, 134.4, 
132.7, 132.0, 131.0, 129.6, 124.8, 72.9, 68.9, 64.3, 24.5.  
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2-[2-(2-mercaptoethoxy)ethoxy]ethyl-2-mercaptobenzoate [ortho-substituted 
aromatic triethylene glycol dithiol (11)]: 63% overall yield, 1H NMR (CDCl3, 400 
MHz) δ 8.03 (d, J = 7.6 Hz, 1H), 7.30 - 7.28 (m, 2H), 7.13 (ddd, J = 8.1, 5.6, 2.9 Hz, 
1H), 4.67 (s, 1H), 4.46 (t, J = 4.8 Hz, 2H), 3.82 (t, J = 4.8 Hz, 2H), 3.69 - 3.57 (m, 6H), 
2.66 (dt, J = 8.2, 6.5 Hz, 2H), 1.55 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 
166.7, 138.3, 132.6, 131.93, 130.9, 126.0, 124.7, 73.0, 70.7, 70.3, 69.2, 64.3, 24.4. 
HRMS (ESI+) calcd for C13H18O4S2 (M + Na)+ 325.05442, obsd 325.0536, (M + H)+ 
303.0724, obsd 303.0718. 
2-[2-(2-(2-mercaptoethoxy)ethoxy)ethoxy]ethyl-2-mercaptobenzoate [ortho- 
substituted aromatic tetraethylene glycol dithiol (12)]: 58% overall yield, 1H NMR 
(CDCl3, 400 MHz) δ 8.03 (d, J = 7.5 Hz, 1H), 7.31 - 7.29 (m, 2H), 7.15 (ddd, J = 8.1, 
5.6, 3.0 Hz, 1H), 4.70 (s, 1H), 4.47 (t, J = 4.8 Hz, 2H), 3.83 (t, J = 4.8 Hz, 2H), 3.70 - 
3.57 (m, 10H), 2.67 (dt, J = 8.2, 6.5 Hz, 2H), 1.57 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 
100 MHz) δ 166.7, 138.7, 132.6, 132.0, 131.0, 126.1, 124.8, 73.0, 70.8, 70.8, 70.7, 70.4, 
69.2, 64.4, 24.4. HRMS (ESI+) calcd for C15H22O5S2 (M + Na)+ 369.0806, obsd. 
369.0788 
2-(2-mercaptoethoxy)ethyl-4-mercaptobenzoate [para-substituted aromatic 
diethylene glycol dithiol (13)]: 95% overall yield, 1H NMR (CDCl3, 400 MHz) δ 7.90 
(d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.45 (t, J = 4.7 Hz, 2H), 3.79 (t, J = 4.8 Hz, 
2H), 3.67 - 3.62 (m, 2H), 2.70 (dt, J = 8.1, 6.3 Hz, 2H), 1.59 (t, J = 8.2 Hz, 1H); 13C 
NMR (CDCl3, 100 MHz) δ 166.1, 138.7, 130.4, 128.2, 127.1, 72.9, 69.0, 64.1, 24.4. 
HRMS (ESI+) calcd for C11H14O3S2 (M + Na)+ 281.0282, obsd 281.0289. 
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2-(2-(2-mercaptoethoxy)ethoxy)ethyl-4-mercaptobenzoate [para-substituted 
aromatic triethylene glycol dithiol (14)]: 59% overall yield, 1H NMR (CDCl3, 400 
MHz) δ 7.90 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.46 (t, J = 4.8 Hz, 2H), 3.83 
(t, J = 4.8 Hz, 2H), 3.71 - 3.60 (m, 6H), 2.68 (dt, J = 8.1, 6.4 Hz, 2H), 1.58 (t, J = 8.2 
Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 166.1, 138.6, 130.4, 128.2, 127.1, 73.0, 70.7, 
70.3, 69.3, 64.1, 24.4. HRMS (ESI+) calcd for C13H18O4S2 (M + Na)+ 325.0544, obsd 
325.0538, C13H18O4S2 (M + H)+ 303.0724, obsd 303.0721. 
2-[2-(2-(2-mercaptoethoxy)ethoxy)ethoxy]ethyl-4-mercaptobenzoate [para -
substituted aromatic tetraethylene glycol dithiol (15)]: 68% overall yield, 1H NMR 
(CDCl3, 400 MHz) δ 7.90 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 4.45 (t, J = 4.8 
Hz, 2H), 3.82 (t, J = 4.8 Hz, 2H), 3.71 - 3.58 (m, 10H), 2.68 (dt, J = 8.1, 6.5 Hz, 2H), 
1.59 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ 166.1, 138.6, 130.4, 128.2, 
127.2, 73.0, 70.8, 70.8, 70.7, 70.3, 69.3, 64.2, 24.4. HRMS (ESI+) calcd for C15H22O5S2 
(M + Na)+ 369.0806, obsd 369.0807.  
 
3.3 Synthesis of aromatic triethylene glycol monothiol (61)126  
3.3.1 Synthesis of aromatic triethylene glycol disulfide (60) 
HO
O
S
2
m = 2
Et3N, CH2Cl2
COCl O O
S
O
m = 2
m
m
2
14%
59
38
60  
Benzoyl chloride (59) (0.646 g, 4.62 mmol) was dissolved in 20 mL of CH2Cl2 
and then transferred to a flask containing triethylene glycol disulfide (38) (0.763 g, 2.31 
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mmol), Et3N (0.964 mL, 6.93 mmol), and 10 mL of CH2Cl2 at 0 oC. The reaction mixture 
was stirred at 0 oC for 30 min and then gradually warmed to room temperature, and 
stirring continued overnight. The reaction mixture was dissolved in 30 mL CH2Cl2 and 
then washed with 50 mL of 0.1 N HCl. The organic layer was then washed with water (2 
x 30 mL), dried (MgSO4), filtered, and reduced under pressure to give the crude oil. The 
crude oil was the purified by flash chromatography using 4:1 hexane:EtOAc to give 0.17 
g of a yellow oil (60), 14% yield. 
1H NMR (CDCl3, 400 MHz) δ 8.05 (d, J = 7.1 Hz, 4H), 7.54 (t, J = 7.4 Hz, 2H), 7.43 (t J 
= 7.9 Hz, 4H), 4.47 (t, J = 4.8 Hz, 4H), 3.83 (t, J = 4.9 Hz, 4H), 3.74 - 3.63 (m, 12H), 
2.86 (t, J = 6.7 Hz, 4H). 
3.3.2 Synthesis of aromatic triethylene glycol monothiol (61) 
 
 
DTT, Et3N
CH2Cl2
O
O
SH
O
m = 2
m
O
O
S
O
m = 2
m
2
57%
60 61  
Triethylamine (0.20 mL, 1.43 mmol) and DTT (0.124 g, 0.315 mmol) were added 
to the disulfide (60) (0.17 g) in 15 mL of CH2Cl2. The reaction mixture was stirred for 2 h 
under argon and then the mixture was extracted with ethyl acetate. The organic layer was 
washed with water (2 x 25 mL), dried over MgSO4, filtered, and concentrated under 
reduced pressure to give the crude product. The crude product was then purified by silica 
gel chromatography using CH2Cl2 to give 0.097 g of aromatic triethylene glycol 
monothiol (61) as an yellow oil, 57% overall yield.  
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1H NMR (CDCl3, 400 MHz) δ 8.04 (d, J = 7.0 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (t J 
= 7.7 Hz, 2H), 4.47 (t, J = 4.8 Hz, 2H), 3.83 (t, J = 3.7 Hz, 2H), 3.70 (t, J = 4.0 Hz, 2H), 
3.65 - 3.58 (m, 4H), 2.66 (q, J = 6.4 Hz, 2H), 1.55 (t, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 
100 MHz) δ 166.6, 133.1, 130.2, 129.8, 128.4, 73.0, 70.8, 70.4, 69.4, 64.2, 24.4. HRMS 
(ESI+) calcd for C13H18O4S (M + Na)+ 293.08235, obsd 293.08230.  
3.4 Synthesis of Di quaternary salt dithiols (Di QAS 16 and 17) 
3.4.1 Synthesis of N1,N3-bis(4-benzoylthio)benzyl)-N1,N1,N3,N3-tetramethylpropane-
1,3-diaminium bromide (67)127         
   
S
Br
O
S
N
O
N Nm
CH3CN
N
S
O
Br
Br
m = 0, 1, 2, 4
99%, 95%, 96%, 99% m
m = 0, 1, 2, 425
62, 63, 64, 65
66, 67, 68, 69  
General procedure 
Benzyl bromide derivative (25) (2.10 g, 6.84 mmol) was added to a stirred 
solution of N,N,N',N'-tetramethyl-1,3-propane diamine (63) (0.38 g, 2.92 mmol) in 20 mL 
of acetonitrile. The reaction mixture was stirred overnight, then the slurry was diluted 
with diethyl ether, filtered, washed with diethyl ether, and dried yielding 2.07 g of a 
white powder (67), 95% yield. 
N1,N2-bis(4-benzoylthio)benzyl)-N1,N1,N2,N2-tetramethylethane-1,2-diaminium 
bromide [TMEDA Salt (66)]: 99% yield, 1H NMR (DMSO, 400 MHz) δ 8.00 (d, J = 
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7.5 Hz, 4H), 7.82 - 7.72 (m, 10H), 7.62 (t, J = 7.8 Hz, 4H), 4.82 (s, 4H), 4.16 (s, 4H), 
3.17 (s, 12H). 13C NMR (DMSO, 100 MHz) δ 188.4, 135.6, 135.2, 134.6, 134.0, 129.8, 
129.4, 128.8, 127.1, 66.7, 55.8, 49.8.  
N1,N3-bis(4-benzoylthio)benzyl)-N1,N1,N3,N3-tetramethylpropane-1,3-diaminium 
bromide [Propane salt (67)]: 95% yield, 1H NMR (DMSO, 400 MHz) δ 8.00 (d, J = 7.4 
Hz, 4H), 7.78 - 7.70 (m, 10H), 7.62 (t, J = 7.8 Hz, 4H), 4.74 (s, 4H), 3.37 (t, J = 8.0 Hz, 
4H), 3.11 (s, 12H), 2.50 - 2.46 (m, 2H). 13C NMR (DMSO, 100 MHz) δ 188.6, 135.7, 
135.2, 134.6, 134.0, 129.6, 129.5, 129.3, 127.2, 66.5, 60.1, 49.7, 16.9. HRMS (ESI+) 
calcd for C35H40Br2N2O2S2 (M - Br)+ 663.1714, obsd 663.1685.  
N1,N4-bis(4-benzoylthio)benzyl)-N1,N1,N4,N4-tetramethylbutane-1,4-diaminium 
bromide [Butane salt (68)]: 96% yield, 1H NMR (DMSO, 400 MHz) δ 7.99 (d, J = 7.2 
Hz, 4H), 7.79 - 7.70 (m, 10H), 7.62 (t, J = 7.9 Hz, 4H), 4.66 (s, 4H), 3.39 (brs, 4H), 3.04 
(s, 12H), 1.84 (brs, 4H). 13C NMR (DMSO, 100 MHz) δ 188.4, 135.6, 135.2, 134.5, 
133.8, 129.5, 129.4, 129.4, 127.1, 66.1, 62.6, 49.4, 19.3. HRMS (ESI+) calcd for 
C36H42Br2N2O2S2 (M - Br)+ 677.1871, obsd 677.1849  
N1,N6-bis(4-benzoylthio)benzyl)-N1,N1,N6,N6-tetramethylhexane-1,6-diaminium 
bromide [Hexane salt (69)]: 99% yield, 1H NMR (DMSO, 400 MHz) δ 7.99 (d, J = 7.3 
Hz, 4H), 7.79 - 7.69 (m, 10H), 7.62 (t, J = 7.9 Hz, 4H), 4.67 (s, 4H), 3.33 (brs, 4H), 3.03 
(s, 12H), 2.07 (brs, 4H), 1.38 (brs, 4H). 13C NMR (DMSO, 100 MHz) δ 188.5, 135.6, 
135.1, 134.5, 133.8, 129.5, 129.3, 127.1, 65.5, 63.5, 49.3, 25.3, 21.7. HRMS (ESI+) calcd 
for C38H46Br2N2O2S2 (M - Br)+ 705.2184, obsd 705.2163.  
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3.4.2 Synthesis of N1,N3-bis(4-mercaptobenzyl)-N1,N1,N3,N3-tetramethylpropane-1,3-
diaminium bromide (Di QAS 16) 
SH
N N
SH
BrBr
1:1 HBr:H2O
130 oC, 90 min
m = 1, 4
m
93%, 51%
S
N
O
N
S
O
BrBr
m = 1, 4
m
67, 69 16, 17  
 
General procedure 
The di quaternary ammonium salt (67) (1.557 g, 2.09 mmol) dissolved in 45 mL 
of water and 45 mL of HBr (48 wt% in water) was refluxed under argon at 130 °C. After 
90 min, the reaction mixture was cooled to 0 °C, filtered, and then washed with EtOAc (3 
x 100 mL). The aqueous layer was reduced partially and then lyophilized several times 
by dissolving the residue in water to give 1.042 g of Di QAS 16 as a white powder, 93% 
yield. 
N1,N3-bis(4-mercaptobenzyl)-N1,N1,N3N3-tetramethylpropane-1,3-diaminium  
bromide (Di QAS 16): 93% yield, 1H NMR (D2O, 400 MHz) δ 7.46 (d, J = 8.4 Hz, 4H), 
7.41 (d, J = 8.4 Hz, 4H), 4.52 (s, 4H), 3.37 (t, J = 8.3 Hz, 4H), 3.09 (s, 12H), 2.41 
(quintet, J = 8.3 Hz, 2H). 13C NMR (D2O, 100 MHz) δ 135.8, 133.5, 129.0, 123.5, 68.5, 
60.1, 49.7, 17.0. HRMS (ESI+) calcd for C21H32Br2N2S2 (M - Br)+ 455.1190, obsd 
455.1175.  
N1,N6-bis(4-mercaptobenzyl)-N1,N1,N3N6-tetramethylhexane-1,3-diaminium  
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bromide (Di QAS 17): 51% yield, 1H NMR (D2O, 400 MHz) δ 7.50 (d, J = 7.2 Hz, 4H), 
7.45 (d, J = 7.7 Hz, 4H), 4.48 (s, 4H), 3.30 (t, J = 8.0 Hz, 4H), 3.08 (s, 12H), 1.92 (brs, 
4H), 1.47 (brs, 4H). 13C NMR (D2O, 100 MHz) δ 135.3, 133.4, 128.9, 124.1, 67.4, 63.8, 
49.6, 25.2, 22.0. HRMS (ESI+) calcd for C24H38Br2N2S2 (M - Br)+ 497.1659, obsd 
497.1638.  
3.5 Enzymatic assays 
3.5.1 Preparation of reduced denatured lysozyme  
Lysozyme (20 mg/mL) was dissolved in 0.1 M Tris-HCl at pH 8.6 which 
contained 6 M Gdn HCl and 0.15 M dithioerythritol (DTE). The protein solution was 
incubated for 2 h at room temperature and then acidified with glacial acetic acid to pH 
3.59,128 The solution was then applied to a column packed with Sephadex G-25 that has 
been pre-equilibrated with 0.1 M acetic acid. The fractions that contained reduced 
lysozyme, as determined by Ellman’s reagent [100 mg of (5,5'-dithiol-bis(2-nitrobenzoic 
acid)) was dissolved in 25 mL of 0.2 M Tris-HCl, pH 8.0, and 25 mL of ethanol], were 
collected and mixed together in a 50 mL centrifuge tube. The fractions containing DTE, 
which eluted from the column after the protein, were discarded. The reduced protein 
concentration was determination by its absorbance at 280 nm using a Cary 300 UV-
visible spectrophotometer (ε280 nm = 2.37 mL mg-1cm-1).129 The reduced lysozyme showed 
no enzymatic activity. The reduced lysozyme was stored at -20 oC as a solid after the 
removal of solvent by lyophilization. 
3.5.2 Calibration of assay for native lysozyme  
Native lysozyme was dissolved in Gdn HCl buffer (6 M Gdn HCl dissolved in 0.1 
M acetic acid) to prepare a stock solution of native lysozyme (approx. 1 mg/mL). The 
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concentration of the stock solution was determined spectrophotometrically by measuring 
the absorbance at 280 nm (ε280 nm = 2.63 mL mg-1 cm-1).129,130 The stock solution of native 
lysozyme was then used to prepare solutions of various concentrations, from 0.01 mg/mL 
to 0.1 mg/mL. The enzymatic assay (vide infra) was then used to determine the activity 
of each solution. The activity was then plotted against native protein concentration. It was 
observed that the rate varied linearly with respect to protein concentration.   
3.5.3 Assay for lysozyme activity129,131,132  
In order to measure the lysozyme activity in all cases, a 20 L aliquot of native or 
renatured lysozyme solution (0.1 mg/mL) was mixed with 980 L of M. Lysodeikticus 
solution (0.25 mg/mL) in 66 mM monobasic potassium phosphate, pH 6.2, equilibrated at 
25 C. The cuvette was inverted repeatedly for 15 s to ensure proper mixing of the 
samples, and then light scattering at 450 nm was monitored for 2 min. The lytic activity 
of lysozyme was determined from the slope of the line. 
3.5.4 Refolding of denatured reduced lysozyme (0.1 mg/mL) 
Reduced lysozyme (10 mg/mL) was dissolved in 0.1 M acetic acid containing 6 
M Gdn HCl at pH 2.5 (280nm = 2.37 mL mg-1 cm-1).59,129,131 The pH of the stock solutions 
containing the thiol or disulfide were also adjusted to the appropriate pH (7.0 or 8.0) with 
1 M KOH prior to use. Refolding of reduced lysozyme was carried out in a deoxygenated 
renaturation buffer [0.1 M bis tris propane-HCl, pH 7.0, 1 mM EDTA, and 0.5 M Gdn 
HCl or 0.1 M Tris-HCl, pH 8.0, 1 mM EDTA, and 0.5 M Gdn HCl, and various 
concentrations of GSH or aromatic dithiols, and GSSG or aromatic disulfide]. In a 1.5 
mL-Eppendorf tube, 10 L of reduced lysozyme (10 mg/mL) was added to 990 L of 
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renaturation buffer (100-fold dilution). For reproducible mixing conditions, the 
renaturation buffer was placed in an Eppendorf tube, the protein was added as a droplet 
on the wall of the tube above the buffer meniscus, and mixing was achieved by vigorous 
agitation with a vortex mixer for 15 s. Subsequently, 20 L aliquots were removed at 
specific times and assayed for enzymatic activity. All the refolding experiments were 
performed at 25 C. 
3.5.5 Refolding of denatured reduced lysozyme (1 mg/mL) 
Reduced lysozyme (11 mg/mL) was dissolved in 0.1 M acetic acid containing 6 
M Gdn HCl at pH 2.5. The pH of the protein solution was then adjusted to that of the 
folding experiment (pH 7.0 or 8.0) by the addition of 3 M KOH. After adjusting the pH, 
the concentration of the protein solution was determined by UV-vis, and the final 
concentration was adjusted to 10 mg/mL with 6 M Gdn HCl, if necessary (280nm = 2.37 
mL mg-1 cm-1).59,129,131 Stock solutions of GSH, aromatic monothiols, aromatic dithiols, 
and GSSG were prepared in deoxygenated 0.1 M bis tris propane-HCl (for pH 7.0) or 0.1 
M Tris-HCl (for pH 8.0), 1.25 M Gdn HCl, and 1 mM EDTA. From the stock solutions, 
varying amount of GSH and GSSG, aromatic monothiol and GSSG, or aromatic dithiols 
and GSSG were mixed in 0.1 M bis tris propane-HCl at pH 7.0 or 0.1 M Tris-HCl at pH 
8.0, 1.25 M Gdn HCl, and 1 mM EDTA and adjusted to the appropriate pH with 1 M 
KOH, if necessary (renaturation buffer). In a 1.5 mL-Eppendorf tube, 900 L of 
renaturation buffer was mixed with 100 L of reduced lysozyme solution (10 mg/mL) to 
give a 10 fold dilution. Subsequently, at specific intervals, 10 L of aliquots were 
withdrawn and diluted with 90 L of buffer (0.1 M bis tris propane-HCl at pH 7.0 or 0.1 
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M Tris-HCl at pH 8.0, 1.25 M Gdn HCl, and 1 mM EDTA) followed by withdrawing 20 
L of the resulting solution and then measuring the enzymatic activity. 
3.6 Determination of pKa values (UV-Vis method)133,134  
Twenty four buffers (50 mM) at a range of pH values: glycine, pH 2.5, 3.0, 3.3; 
2,2-dimethoxysuccinate, pH 3.7, 4.0, 4.3, 4.7, 5.0, 5.3, 5.7, 6.0, 6.3, 6.7; Tris, pH 7.0, 7.3, 
7.7, 8.0, 8.3, 8.7; glycine, pH 9.0, 9.5, 10.0, 10.5; H3PO4, pH 11.0 were prepared. An 
ethanolic solution (100 mM) of the aromatic thiol or dithiol was diluted by 100-1000 fold 
using a high or low pH buffer until the absorbance was 1.5. Then the absorbance of the 
given aromatic thiol or dithiol was measured in buffers whose pH would fall within 1.5 
units of the pKa of the thiol tested. The absorbance of the selected thiol or dithiol in each 
buffers was measured at the λmax, of the corresponding thiolate or thiol. The absorbance 
was plotted against the pH and then compared with a plot derived from theory. The pKa 
was determined from the best fit curve. 
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Chapter 4 
Results and discussion 
 Results and discussion will be divide into four section.  
1) The synthesis of aromatic monothiols and their corresponding disulfides will be 
described. Additionally, the folding of bovine pancreatic trypsin inhibitor (by Ms. Shweta 
Mandumula) and the folding of lysozyme (by Dr. David Madar) using aromatic 
monothiols and their corresponding disulfides will be presented.  
2) The synthesis of ortho- and para-substituted aromatic ethylene glycol dithiols and 
their effect on the folding of lysozyme (0.1 mg/mL) will be discussed. 
3) The synthesis of quaternary ammonium aromatic dithiols and the activity of these 
compounds on the folding of lysozyme (1 mg/mL) will be discussed.  
4) The thiol pKa values of aromatic monothiols and dithiols will be presented. 
4.1 Synthesis of aromatic monothiols (1-4) and their corresponding disulfides (5-8), 
and their folding studies 
 Initially, a series of aromatic monothiols with a range of thiol pKa values, such as 
4-mercaptobenzoic acid (1), 4-mercaptobenzylphosphonic acid (2), quaternary 
ammonium salt (3), and 4-mercaptobenzenesulfonic acid (4), and their corresponding 
disulfides (5-8) were synthesized. The above compounds were synthesized on a 
multigram scale in 4-5 steps. Compounds 1-4 were selected on the basis of their thiol pKa 
values (5-7) and water solubility (>10 mM). The pKa value of the aromatic thiols were 
expected to be similar to that of PDI.135 As most protein folding assays are performed in 
aqueous media close to neutral pH, the aromatic thiols selected were expected to be 
soluble at pH 7 in both the thiol and disulfide form. 
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4.1.1 Synthesis of 4-mercaptobenzoic acid (1) and its disulfide (5) 
 The synthesis of 4-mercaptobenzoic acid (1) was performed from readily 
available methyl 4-hydroxybenzoate (18). Methyl 4-hydroxybenzoate (18) on treatment 
with DABCO and N,N-dimethylthiocarbamoyl chloride (19) gave compound (20) which 
on heating at 210-240 oC underwent rearrangement to form compound (21). Next, 
compound (21) was hydrolyzed by treating with NaOH and methanol to give 4-
mercaptobenzoic acid (1) (Scheme 3). The disulfide of 4-mercaptobenzoic acid (5) was 
synthesized by dissolving 4-mercaptobenzoic (1) acid in ethanol and adding a saturated 
solution of I2 in 95% ethanol until a light yellow color persisted. The mixture was filtered 
to give 4-mercaptobenzoic acid disulfide (5) as an off white solid (Scheme 3).  
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Scheme 3. Synthesis of 4-mercaptobenzoic acid (1) and its disulfide (5) 
4.1.2 Synthesis of 4-mercaptobenzylphosphonic acid (2) 
 The 4-mercaptobenzylphosphonic acid (2) and quaternary ammonium salt (3) 
were synthesized through a common intermediate, bromo derivative (25). 4-
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Mercaptobenzylphosphonic acid (2) was synthesized by treating p-toluene thiol (22) with 
benzoyl chloride (23) to form compound (24). Compound (24) was then treated with N-
bromosuccimide to form bromo derivative (25) which on treatment with triethylphosphite 
produced phosphonic acid derivative (26). Previously, phosphonic acid derivative (26) 
was purified by column chromatography followed by recrystallization. I improved upon 
this method by cooling the reaction mixture to - 5 oC, which precipitated out the product. 
The solid residue was then recrystallized to yield the phosphonic acid (26). By avoiding 
the column chromatography step, I saved time, improved the yield, and was able to 
perform the reaction on a large scale. Phosphonic acid derivative (26) was then reacted  
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Scheme 4. Synthesis of 4-mercaptobenzylphosphonic acid (2) and its disulfide (6) 
with sodium ethoxide/ethanol followed by acetic anhydride to change the benzoyl 
protecting group to an acetyl protecting group, thus preventing benzoic acid from 
precipitating out of the solution along with the 4-mercaptobenzylphosphonic acid (2) in 
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the next step. Next, the acetyl protected group was hydrolyzed by refluxing with conc 
HCl to give 4-mercaptobenzylphosphonic acid (2) (Scheme 4). The disulfide of 4-
mercaptobenzylphosphonic acid (6) was synthesized for the first time by vigorously 
stirring the corresponding thiol (2) in water for 1 week (Scheme 4). 
4.1.3 Synthesis of quaternary ammonium thiol salt (Mono QAS 3) and its disulfide 7 
 Mono QAS 3 was synthesized from bromo derivative (25), one of the 
intermediates in the synthesis of 4-mercaptobenzylphosphonic acid (2). The bromo 
derivative (25) was reacted with trimethylamine to form quaternary ammonium salt (28) 
in 81% yield, which on hydrolysis with conc HBr:H2O (1:5) gave quaternary ammonium 
thiol (3) in quantitative yield (Scheme 5). The disulfide of the quaternary ammonium salt 
(7) was synthesized by vigorously stirring the corresponding thiol (3) in water for 6 
months (Scheme 5).      
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Scheme 5. Synthesis of Mono QAS (3) and its disulfide (7) 
4.1.4 Synthesis of 4-mercaptobenzenesulfonic acid (4) and its disulfide (8)  
 The 4-Mercaptobenzenesulfonic acid (4) was synthesized from readily available 
4-aminobenzenesulfonic acid (29). 4-Aminobenzenesulfonic acid (29) was dissolved in a 
solution of NaOH in water, and then conc HCl was added. To the resulting suspension, a 
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solution of sodium nitrite in water was added, and the mixture was poured into a solution 
of sodium disulfide. The insoluble material was filtered off and a solution of aniline and 
conc HCl in water was added to the filtrate. The precipitate was filtered, recrystallized  
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Scheme 6. Synthesis of 4-mercaptobenzenesulfonic acid (4) and disulfide of Na salt of 4-
mercaptobenzenesulfonic acid (8) 
 
from water, and washed with ethanol and hexane to give the dianilinium salt (30). The 
dianilinium ions (30) were exchanged for hydrogen ions by ion exchange 
chromatography, and then the disulfide (31) was reduced by treating with 
triphenylphosphine in the presence of water and methanol to form 4-
mercaptobenzenesulfonic acid (4) (Scheme 6). The disulfide of 4-
mercaptobenzenesulfonic acid (8) was formed as its sodium salt by exchanging the 
anilinium ions (30) with sodium ions by ion exchange chromatography (Scheme 6 ).                                  
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4.1.5 Folding studies with aromatic monothiols and their disulfides 
4.1.5.1 Folding of BPTI in the presence of GSSG, phosphonic acid disulfide (6), 
quaternary ammonium salt disulfide (7), and sulfonic acid disulfide (8)  
 A folding intermediate of BPTI, N*, was folded in the presence of various 
concentrations of GSSG and more reactive small molecule aromatic disulfides (6), (7), 
and (8) by Ms. Shweta Mandumula (Figure 18 a-c). It was observed that the folding rate 
increased as the thiol pKa of the corresponding thiol decreased. As aromatic thiols have 
lower thiol pKa values, aromatic thiols act as better leaving group than GSH during 
thiol/disulfide interchange reactions. It was also observed that by increasing the disulfide 
concentration the folding rate of N* increased.  
a) 
N*
N
Retention Time (min) 
1
280
560
960
Re
fo
ldi
ng
 T
im
e 
(m
in)
 
b)
N
N*
Retention Time (min)
1
60
120
240
Re
fo
ld
in
g 
Ti
m
e 
(m
in
)
                
  74 
 
 N
N* Mixed Disulfides
Retention Time (min)
1
8
16
4
Re
fo
ldi
ng
 T
im
e 
(m
in)
 
                                   c) 
Figure 18. HPLC chromatograms of a folding mixture of BPTI at different time intervals 
in the presence of (a) 10 mM GSSG, (b) 0.25 mM phosphonic acid disulfide (6), and (c) 
0.25 mM sulfonic acid disulfide (8). 
 
 Creighton and Kim proposed folding models for BPTI which indicated that N* 
does not undergo direct oxidation to native protein, but rearranges to N' and then 
NSH.40,93,136 N' and then NSH are subsequently oxidized to native protein. However, the 
above results shows that N* does undergoes direct oxidation to N. Furthermore, the 
results demonstrate that small molecule aromatic disulfides enhance the folding rate 
constants of N* to N by 100-3000 fold as compared to GSSG.  
4.1.5.2 Folding of lysozyme with aromatic monothiols (2 and 3) and their 
corresponding disulfides (6 and 7) 
 All in vitro folding experiments with lysozyme were performed at pH 7.0 or 8.0 
and at a higher protein concentration (1 mg/mL) than traditionally used (0.1 mg/mL). In 
vitro folding was carried out using various concentrations of phosphonic acid monothiol 
(2) and its disulfide (6) or quaternary ammonium salt (3) and its disulfide (7) in 
comparison with 7 mM GSH and 2 mM GSSG by Dr. David Madar. At pH 7.0, aromatic 
thiol (2) and its disulfide (6) or aromatic thiol (3) and its disulfide (7) increased the 
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folding rate up to 11 times and improved the yields between 20 and 40% as compared to 
GSH/GSSG. At pH 8.0, aromatic thiol (2) and its disulfide (6) or aromatic thiol (3) and 
its disulfide (7) increased the folding rate up to 7 times and improved the yields up to 
25% as compared to GSH/GSSG (Figure 19 a-d). 
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Figure 19. Folding of lysozyme at 1mg/mL (a) At pH 7.0 with (▲) 2 mM 2/1 mM 6, (■) 
5 mM 2/1 mM 6, (♦) 10 mM 2/1 mM 6, (●) 20 mM 2/1 mM 6, and (▼) 7 mM GSH/2 
mM GSSG. (b) At pH 8.0 with (▲) 10 mM 2/0.5 mM 6, (■) 20 mM 2/0.5 mM 6, (♦) 10 
mM 2/1 mM 6, (●) 20 mM 2/1 mM 6, and (▼) 7 mM GSH/2 mM GSSG. (c) At pH 7.0 
with (▲) 10 mM 3/0.5 mM 7, (■) 20 mM 3/0.5 mM 7, (♦) 20 mM 3/1 mM 7, (●) 20 mM 
3/2 mM 7, and (▼) 7 mM GSH/2 mM GSSG. (d) At pH 8.0 with (▲) 10 mM 3/1 mM 7, 
(■) 20 mM 3/1 mM 7, (♦) 20 mM 3/2 mM 7, (●) 50 mM 3/2 mM 7, and (▼) 7 mM 
GSH/2 mM GSSG. 
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4.2 Synthesis of aromatic dithiols (9-15) 
The aim of the project was to increase the in vitro folding rates and yields of 
disulfide containing proteins by combining the advantageous properties of aliphatic 
dithiols and aromatic monothiols. Raines et al. have demonstrated that aliphatic dithiols 
increase the in vitro folding yield of RNase A relative to aliphatic monothiols, while Lees 
et al. have shown that aromatic monothiols increase in vitro folding rates of RNase A and 
lysozyme relative to aliphatic monothiols.4,32,35,38,117 Thus, I planned to synthesize dithiols 
containing an aromatic thiol group. The compounds were designed to mimic PDI, such 
that one thiol group is more reactive than the other. Hence, the more reactive thiol group 
was present on an aromatic ring and the other less reactive thiol group was on an aliphatic 
chain. Additionally, the compounds should be aqueous soluble from pH 6.0 to 8.0, the pH 
range used to fold most proteins in vitro. Therefore, polyethylene groups were inserted 
into the aliphatic chain to improve solubility. Furthermore, ortho- and para-substituted 
aromatic ethylene glycol dithiols were selected to provide a wide range of thiol pKa 
values (5-7). The ortho- and para- substituted aromatic ethylene glycol dithiols consisted 
of one thiol group on the aromatic ring and a second thiol group on the free end of a 
polyethylene glycol chain. The aliphatic chain of polyethylene glycol was connected to 
the aromatic ring via an esterification reaction.  
4.2.1 Synthesis of ortho- and para-substituted aromatic ethylene glycol dithiols (9-
15) 
To synthesizes ortho- and para- series of aromatic ethylene glycol dithiols (9-15), 
ethylene glycol disulfides (37, 38, and 45) were synthesizes first. Ethylene glycol 
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disulfides (37, 38, and 45) were prepared as shown below. These ethylene glycol 
disulfides (37, 38, and 45) were then treated with acid chloride (49) to prepare ortho-
substituted aromatic ethylene glycol dithiols or acid chloride (55) to prepare para-
substituted aromatic ethylene glycol dithiols. 
4.2.1.1 Synthesis of di-, tri-, tetra- and hexaethylene glycol disulfides (37, 38, 45, and 
46) 
Treatment of di- and triethylene glycol chlorides (33) and (34) with thiourea (32) 
followed by hydrolysis with NaOH gave di- and triethylene glycol thiols (35) and (36), 
respectively. Thiols (35) and (36) were then subjected to air oxidation for 1 week to give 
the corresponding disulfides (37) and (38), respectively, (Scheme 7). Tetra- and 
hexaethylene glycol disulfides, (45) and (46), were prepared by treating tetra- and 
hexaethylene glycol, (39) and (40), respectively, with p-toluenesulfonyl chloride to form  
H2N NH2
S
2) NaOH
3) HCl
O2
HO
O
Sm 2
m = 1, 2
m = 1, 2 m = 1, 2
1) reflux
45%, 84%
59%, 67%
32
37, 38
33, 34
35, 36
HO
O
Clm
HO
O
SHm
 
Scheme 7. Synthesis of di- and triethylene glycol disulfides (37 and 38) 
 
their respective monotosylates (41) and (42). The monotosylates (41) and (42) were then 
treated with thiourea to form the tetra- and hexaethylene glycol thiols (43) and (44), 
respectively. The tera- and hexaethylene glycol thiols, (43) and (44), were then subjected 
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to air oxidation by stirring vigorously in water for 1 week to form the corresponding 
disulfides (45) and (46), respectively (Scheme 8). 
O
OH
OH p-TsCl, NEt3
     16 h
O
O
OH
Ts
1. Thiourea
    EtOH, 24 h
O
SH
OH O
S
OH
2
O2
2. NaOH/EtOH
    H2O, 2.5 h
m m
m m
m = 3, 5
m = 3, 5
45%, 50%
89%, 58%
91%, 95%
m = 3, 5
m = 3, 5
39, 40 41, 42
43, 44 45, 46  
Scheme 8. Synthesis of tetra- and hexaethylene glycol disulfides (45 and 46) 
 
4.2.1.2 Synthesis of ortho-substituted aromatic mono-, di-, tri-, and tetraethylene 
glycol dithiols (9-12) 
DTT, Et3N
CH2Cl2
Cl
Cl
O
O
DMF, THF
HO
O
S
2
m = 0, 1, 2, 3
Et3N, CH2Cl2COOH
S
COCl
S
22
S
O
O
S
O
m = 0, 1, 2, 3
m
SH
O
O
SH
O
m = 0, 1, 2, 3
m
m
n
Overall yield
46%, 30%, 63%, 58%
 47  49 50, 37, 38, 45
51, 52, 53, 54 9, 10, 11, 12
48
 
 
Scheme 9. Synthesis of ortho-substituted aromatic mono-, di-, tri-, and tetraethylene 
glycol dithiols (9-12) 
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 The first step in the synthesis of ortho-substituted aromatic mono-, di-, tri-, and 
tetraethylene glycol dithiols (9-12) involved the treatment of readily available 
dithiosalicylic acid (47) with oxalyl chloride (48) and DMF in THF to produce an acid 
chloride (49). In the same pot, the acid chloride (49) was then treated with mono-, di-, tri- 
and tetraethylene glycol disulfides (50, 37, 38, and 45) to form their respective polymer 
(51-54). The polymers (51-54) was then reduced with DTT in the presence of a base, 
Et3N, to give ortho-substituted aromatic mono-, di-, tri- and tetra ethylene glycol dithiols 
(9-12), respectively, (Scheme 9). 
4.2.1.3 Synthesis of para-substituted aromatic di-, tri-, and tetraethylene glycol 
dithiols (13-15) 
 
DTT, Et3N
CH2Cl2
S
COOH
2
S
COCl
2Cl
Cl
O
O
DMF, THF
HO O S
m 2
m = 1, 2, 3
Et3N, CH2Cl2
m =  1, 2, 3
S
O
  Overall yield
O O Sm n
m =  1, 2, 3
S
O
O O Sm n
m =  1, 2, 3
SH
O
O O SHm
95%, 59%, 68%
5
48
55
37, 38, 45
56, 57, 58
56, 57, 58 13, 14, 15  
 
Scheme 10. Synthesis of para-substituted aromatic di-, tri-, and tetraethylene glycol 
dithiols (13-15) 
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 The para-substituted aromatic di-, tri-, and tetraethylene glycol dithiols (13-15) 
were synthesized in the same manner as the ortho-substituted aromatic ethylene glycol 
dithiols (Scheme 10). The only difference between the synthesis of the ortho- and para- 
series of compounds was that the disulfide of 4-mercaptobenzoic acid (5) was used 
instead of dithiosalicylic acid (47).  
 ortho- and para- Substituted aromatic dithiols (11, 12, 14, and 15) were then 
examined for their ability to fold reduced lysozyme. Lysozyme was selected as this 
enzyme has been extensively studied, and its folding pathway has been well 
characterized.37,85,129,137-139 The folding of reduced lysozyme was carried out in the 
presence of various concentrations of aromatic dithiols (11, 12, 14, and 15) in 
combination with either 0.2 mM GSSG or 2 mM GSSG. These concentrations of GSSG 
were selected as our previous results obtained with RNase A and lysozyme used 0.2 mM 
or 2 mM GSSG.4,35-37 These folding experiments were then compared directly with 7 mM 
GSH and 2 mM GSSG. These concentrations of GSH and GSSG were selected for the 
folding experiments as they gave the best combination of folding rate and yield in our 
previous study at 0.1 mg/mL lysozyme concntration.37 All the folding experiments were 
carried out at pH 7.0 and 8.0, and 0.1 mg/mL (7 µM) lysozyme concentration at 25 oC. 
 The folding of lysozyme was followed using the recovery of enzymatic activity. 
Reduced lysozyme (10 mg/mL), from which the dithioerythritol (DTE) had been 
removed by gel permeation chromatography, was diluted 100-fold into renaturation 
buffer containing 0.1 M buffer (bis tris propane-HCl for pH 7.0 or Tris-HCl for pH 8.0), 
1 mM EDTA, 0.5 M guanidine hydrochloride (Gdn HCl), and redox buffer.131,140 The use 
of EDTA was to prevent metal catalyzed air oxidation of thiols.129 To minimize protein 
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aggregation during folding, Gdn HCl was added.27,131 At specific times, aliquots were 
removed from the folding reaction and the enzymatic activity was determined by adding 
the aliquots to a suspension of M. lysodeikticus.129,131,132 The decrease in light scattering 
was monitored at 450 nm for 2 min. The change in light scattering per minute is 
proportional to enzymatic activity. 
4.2.1.4 Folding of lysozyme with ortho-substituted aromatic ethylene glycol dithiols 
(11 and 12) 
 Initially a range of concentrations was examined to find the best concentrations of 
dithiols (11 and 12) for the folding of lysozyme. At 20 mM, ortho-substituted aromatic 
ethylene glycol dithiols (11 and 12) were only partially soluble in 0.1 M bis tris propane-
HCl buffer (pH 7.0) and 0.1 M Tris-HCl buffer (pH 8.0). The solubility of dithiols (11 
and 12) was determined by Ellman’s method.141 The solubility of ortho-substituted 
aromatic tri- and tetraethylene glycol dithiols (11 and 12) was found to be 4 and 10 mM 
at pH 7.0, respectively, and 10 and 20 mM at pH 8.0, respectively. Thus, the 
concentrations of triethylene glycol dithiol (11) examined were in the range of 0.25 to 2 
mM at pH 7.0 and 0.25 to 10 mM at pH 8.0, whereas that of tetraethylene glycol dithiol 
(12) were in the range of 0.25 to 10 mM at both pH 7.0 and 8.0. The folding experiments 
were then performed with tri- and tetraethylene glycol dithiols (11 and 12) in 
combination with either 0.2 or 2 mM GSSG at pH 7.0 and pH 8.0 (Tables 1 and 2, 
Figures 20-23).  
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Figure 20. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of ortho-substituted aromatic triethylene 
glycol dithiol (11); (b) under standard conditions or 2 mM GSSG and various 
concentrations of ortho-substituted aromatic triethylene glycol dithiol (11).(a) (●) 7 mM 
GSH/2 mM GSSG (standard conditions), (■) 0.25 mM 11/0.2 mM GSSG, (♦) 0.50 mM 
11/0.2 mM GSSG, (▼) 1.0 mM 11/0.2 mM GSSG, and (▲) 2.0 mM 11/0.2 mM GSSG; 
(b) (●) 7 mM GSH/2 mM GSSG (standard conditions), (■) 0.25 mM 11/2 mM GSSG, (♦) 
0.50 mM 11/2 mM GSSG, (▼) 1.0 mM 11/2 mM GSSG, and (▲) 2.0 mM 11/2 mM 
GSSG. 
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Figure 21. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of ortho-substituted aromatic triethylene 
glycol dithiol (11); (b) under standard conditions or 2 mM GSSG and various 
concentrations of ortho-substituted aromatic triethylene glycol dithiol (11). (a) (●) 7 mM 
GSH/2 mM GSSG (standard conditions), (▼) 1 mM 11/0.2 mM GSSG, (▲) 2 mM 
11/0.2 mM GSSG, () 4.0 mM 11/0.2 mM GSSG, and ()7.0 mM 11/0.2 mM GSSG; 
(b) (●) 7 mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 11/2 mM GSSG, (▼) 
1.0 mM 11/2 mM GSSG, (▲) 2.0 mM 11/2 mM GSSG, (Δ) 3.0 mM 11/2 mM GSSG, 
and () 10.0 mM 11/2 mM GSSG.  
  
  83 
 
0
20
40
60
80
100
0 100 200 300
%
 A
ct
iv
ity
Time (min)
a
 
0
20
40
60
80
100
0 100 200 300
%
 A
ct
iv
ity
Time (min)
b
 
Figure 22. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of ortho-substituted aromatic tetraethylene 
glycol dithiol (12); (b) under standard conditions or 2 mM GSSG and various 
concentrations of ortho-substituted aromatic tetraethylene glycol dithiol (12). (a) (●) 7 
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 12/0.2 mM GSSG, (▼) 1.0 
mM 12/0.2 mM GSSG, (▲) 2.0 mM 12/0.2 mM GSSG, (Δ) 3.0 mM 12/0.2 mM GSSG 
and () 10.0 mM 12/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard 
conditions), (■) 0.25 mM 12/2 mM GSSG, (♦) 0.5 mM 12/2 mM GSSG, (▼) 1.0 mM 
12/2 mM GSSG, (▲) 2.0 mM 12/2 mM GSSG, and (Δ) 3.0 mM 12/2 mM GSSG. 
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Figure 23. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of ortho-substituted aromatic tetraethylene 
glycol dithiol (12); (b) under standard conditions or 2 mM GSSG and various 
concentrations of ortho-substituted aromatic tetraethylene glycol dithiol (12). (a) (●) 7 
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 12/0.2 mM GSSG, (▼) 1.0 
mM 12/0.2 mM GSSG, (▲) 2.0 mM 12/0.2 mM GSSG, (Δ) 3.0 mM 12/0.2 mM GSSG, 
and () 10.0 mM 12/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard 
conditions), (♦) 0.5 mM 12/2 mM GSSG, (▼) 1.0 mM 12/2 mM GSSG, (▲) 2.0 mM 
12/2 mM GSSG, (Δ) 3.0 mM 12/2 mM GSSG, and () 10.0 mM 12/2 mM GSSG. 
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Table 1. Folding of lysozyme with ortho-substituted aromatic triethylene glycol dithiol 
(11) at pH 7.0 and 8.0 
 
 The folding of lysozyme in the presence of aromatic dithiols (11 and 12) was 
compared by fitting the data to a single exponential function. The exponential function 
used was y =A(1- e –kt), where A is the maximal enzymatic activity achieved, k is the 
apparent folding rate constant, and t is time. The initial folding rate corresponds to A*k. 
pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.25 mM 11/0.2 mM GSSG 66 0.013 0.9 
0.5 mM 11/0.2 mM GSSG 55 0.002 0.1 
1 mM 11/0.2 mM GSSG 20 0.004 0.1 
2 mM 11/0.2 mM GSSG 19 0.001 0.0 
0.25 mM 11/2 mM GSSG 26 0.015 0.4 
0.5 mM 11/2 mM GSSG 43 0.012 0.5 
1 mM 11/2 mM GSSG 63 0.013 0.8 
2 mM 11/2 mM GSSG 62 0.016 0.9 
7 mM GSH/2 mM GSSG 82 0.010 0.8 
pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
1 mM 11/0.2 mM GSSG 58 0.04 2.3 
2 mM 11/0.2 mM GSSG 62 0.009 0.6 
4 mM 11/0.2 mM GSSG 9 0.014 0.1 
7 mM 11/0.2 mM GSSG 0 0.159 0.2 
0.5 mM 11/2 mM GSSG 83 0.026 2.2 
1 mM 11/2 mM GSSG 81 0.049 4.0 
2 mM 11/2 mM GSSG 75 0.073 5.5 
3 mM 11/2 mM GSSG 57 0.049 2.8 
10 mM 11/2 mM GSSG 0 0.107 0.0 
7 mM GSH/2 mM GSSG 84 0.050 4.2 
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The A, k, and A*k  values for ortho-substituted aromatic tri- and tetraethylene glycol 
dithiols (11 and 12) are shown in Tables 1 and 2.  
Table 2. Folding of lysozyme with ortho-substituted aromatic tetraethylene glycol dithiol 
(12) at pH 7.0 and 8.0 
 
pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 12/0.2 mM GSSG 85 0.008 0.7 
1 mM 12/0.2 mM GSSG 62 0.009 0.5 
2 mM 12/0.2 mM GSSG 30 0.007 0.2 
3 mM 12/0.2 mM GSSG 2 0.010 0.02 
10 mM 12/0.2 mM GSSG 0 0.190 0.3 
0.25 mM 12/2 mM GSSG 45 0.004 0.2 
0.5 mM 12/2 mM GSSG 60 0.005 0.3 
1 mM 12/2 mM GSSG 69 0.007 0.5 
2 mM 12/2 mM GSSG 69 0.012 0.8 
3 mM 12/2 mM GSSG 84 0.01 0.8 
7 mM GSH/2 mM GSSG 87 0.010 0.9 
pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 12/0.2 mM GSSG 76 0.061 4.7 
1 mM 12/0.2 mM GSSG 62 0.052 3.2 
2 mM 12/0.2 mM GSSG 45 0.028 1.3 
3 mM 12/0.2 mM GSSG 27 0.023 0.6 
10 mM 12/0.2 mM GSSG 0 0.322 0.5 
0.5 mM 12/2 mM GSSG 81 0.018 1.5 
1 mM 12/2 mM GSSG 69 0.068 4.7 
2 mM 12/2 mM GSSG 55 0.072 4.0 
3 mM 12/2 mM GSSG 45 0.065 3.0 
10 mM 12/2 mM GSSG 1 0.299 0.4 
7 mM GSH/2 mM GSSG 87 0.047 4.0 
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4.2.1.5. Folding of lysozyme with para -series of aromatic ethylene glycol dithiols 
(14 and 15) 
 Folding experiments with lysozyme using para-substituted aromatic tri- and 
tetraethylene glycol dithiols (14 and 15) were also performed. In a similar manner as 
ortho-substituted aromatic tri- and tetraethylene glycol dithiols (11and 12), a range of 
concentrations was examined to find the best concentrations of dithiols 14 and 15. Unlike 
dithiols 11 and 12, dithiols 14 and 15 were soluble ( >20 mM) in 0.1 M bis tris propane-
HCl buffer (pH 7.0) and 0.1 M Tris-HCl buffer (pH 8.0). The concentrations of dithiols 
14 and 15 examined were in the range of 0.5 to 10 mM at pH 7.0 and 8.0. Although 
dithiols 14 and 15 were soluble in 0.1 M bis tris propane-HCl buffer (pH 7.0) and 0.1 M 
Tris-HCl buffer (pH 8.0), concentrations above 10 mM were not used for folding studies 
as the protein showed little or no activity at 10 mM. Folding experiments were carried out 
using various concentrations of dithiols 14 and 15 in combination with either 0.2 or 2 
mM GSSG at pH 7.0 and 8.0. (Tables 3 and 4, Figures 24-27). These folding experiments 
were then done simultaneously with the standard conditions, 7 mM GSH and 2 mM 
GSSG. The folding of lysozyme in the presence of dithiols 14 and 15 was then compared 
by fitting the data to a single exponential function, y =A(1- e –kt). The A, k, and A*k  
values for dithiols 14 and 15 are shown in the tables 3 and 4.      
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Figure 24. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of para-substituted aromatic triethylene glycol 
dithiol (14); (b) under standard conditions or 2 mM GSSG and various concentrations of 
para-substituted aromatic triethylene glycol dithiol (14). (a) (●) 7 mM GSH/2 mM GSSG 
(standard conditions), (♦) 0.5 mM 14/0.2 mM GSSG, (▼) 1.0 mM 14/0.2 mM GSSG, 
(▲) 2.0 mM 14/0.2 mM GSSG, (Δ) 3.0 mM 14/0.2 mM GSSG, and () 10.0 mM 14/0.2 
mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 14/2 
mM GSSG, (▼) 1.0 mM 14/2 mM GSSG, (▲) 2.0 mM 14/2 mM GSSG and (Δ) 3.0 mM 
14/2 mM GSSG. 
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Figure 25. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of para-substituted aromatic triethylene glycol 
dithiol (14); (b) under standard conditions or 2 mM GSSG and various concentrations of 
para-substituted aromatic triethylene glycol dithiol (14). (a) (●) 7 mM GSH/2 mM GSSG 
(standard conditions), (♦) 0.5 mM 14/0.2 mM GSSG, (▼) 1.0 mM 14/0.2 mM GSSG, 
(▲) 2.0 mM 14/0.2 mM GSSG, and (Δ) 3.0 mM 14/0.2 mM GSSG; (b) (●) 7 mM GSH/ 
2 mM GSSG (standard conditions), (♦) 0.5 mM 14/2 mM GSSG, (▼) 1.0 mM 14/2 mM 
GSSG, (▲) 2.0 mM 14/2 mM GSSG and (Δ) 3.0 mM 14/2 mM GSSG. 
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Figure 26. Folding of lysozyme (0.1 mg/mL) at pH 7.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of para-substituted aromatic tetraethylene 
glycol dithiol (15); (b) under standard conditions or 2 mM GSSG and various 
concentrations of para-substituted aromatic tetraethylene glycol dithiol (15). (a) (●) 7 
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 15/0.2 mM GSSG, (▼) 1.0 
mM 15/0.2 mM GSSG, (Δ) 3.0 mM 15/0.2 mM GSSG, and () 10.0 mM 15/0.2 mM 
GSSG; (b (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 15/2 mM 
GSSG, (▼) 1.0 mM 15/2 mM GSSG, (▲) 2.0 mM 15/2 mM GSSG, (Δ) 3.0 mM 15/2 
mM GSSG, and () 10.0 mM 15/2 mM GSSG. 
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Figure 27. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of para-substituted aromatic tetraethylene 
glycol dithiol (15); (b) under standard conditions or 2 mM GSSG and various 
concentrations of para-substituted aromatic tetraethylene glycol dithiol (15). (a) (●) 7 
mM GSH/2 mM GSSG (standard conditions), (♦) 0.5 mM 15/0.2 mM GSSG, (▼) 1.0 
mM 15/0.2 mM GSSG, (▲) 2.0 mM 15/0.2 mM GSSG, and (Δ) 3.0 mM 15/0.2 mM 
GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 15/2 mM 
GSSG, (▼) 1.0 mM 15/2 mM GSSG, (▲) 2.0 mM 15/2 mM GSSG, (Δ) 3.0 mM 15/2 
mM GSSG, and () 10.0 mM 15/2 mM GSSG. 
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Table 3. Folding of lysozyme with para-substituted aromatic triethylene glycol dithiol 
(14) at pH 7.0 and 8.0 
 
 
An increase in the overall yield of native protein with both series of aromatic dithiols (11, 
12, 14, and 15) was expected, because of the presence of the second thiol group on the 
aliphatic chain in comparison with 7 mM GSH and 2 mM GSSG. However, a general 
pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 14/0.2 mM GSSG 57 0.025 1.4 
 1 mM 14/0.2 mM GSSG 50 0.028 1.4 
 2 mM 14/0.2 mM GSSG 36 0.024 0.9 
 3 mM 14/0.2 mM GSSG 23 0.020 0.5 
10 mM 14/0.2 mM GSSG 0.5 0.058 0.03 
 0.5 mM 14/2 mM GSSG 41 0.012 0.5 
    1 mM 14/2 mM GSSG 44 0.019 0.9 
  2 mM 14/2 mM GSSG 40 0.032 1.3 
  3 mM 14/2 mM GSSG 34 0.035 1.2 
7 mM GSH/2 mM GSSG 83 0.010 0.9 
pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 14/0.2 mM GSSG 63 0.076 4.8 
1 mM 14/0.2 mM GSSG 51 0.082 4.2 
2 mM 14/0.2 mM GSSG 31 0.088 2.7 
3 mM 14/0.2 mM GSSG 16 0.103 1.6 
0.5 mM 14/2 mM GSSG 61 0.036 22 
    1 mM 14/2 mM GSSG 43 0.069 3.0 
   2 mM 14/2 mM GSSG 16 0.285 4.5 
  3 mM 14/2 mM GSSG 2 0.820 1.5 
7 mM GSH/2 mM GSSG 85 0.070 6.0 
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decreased in the overall yield of native protein with both series of aromatic dithiols (11, 
12, 14, and 15) was observed. 
Table 4. Folding of lysozyme with para-substituted aromatic tetraethylene glycol dithiol 
(15) at pH 7.0 and 8.0 
 
 
 
pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 15/0.2 mM GSSG 39 0.038 1.5 
1 mM 15/0.2 mM GSSG 40 0.050 2.0 
3 mM 15/0.2 mM GSSG 36 0.045 1.6 
10 mM 15/0.2 mM GSSG 13 0.066 0.8 
0.5 mM 15/2 mM GSSG 54 0.008 0.4 
    1 mM 15/2 mM GSSG 58 0.017 1.0 
  2 mM 15/2 mM GSSG 49 0.040 2.0 
  3 mM 15/2 mM GSSG 38 0.054 2.0 
10 mM 15/2 mM GSSG 0 0.081 0.02 
7 mM GSH/2 mM GSSG 83 0.011 0.9 
pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 15/0.2 mM GSSG 73 0.087 6.4 
1 mM 15/0.2 mM GSSG 69 0.096 6.7 
2 mM 15/0.2 mM GSSG 61 0.086 5.3 
3 mM 15/0.2 mM GSSG 43 0.072 3.1 
0.5 mM 15/2 mM GSSG 39 0.061 2.4 
    1 mM 15/2 mM GSSG 54 0.028 1.5 
2 mM 15/2 mM GSSG 22 0.192 4.2 
3 mM 15/2 mM GSSG 10 0.354 3.7 
10 mM 15/2 mM GSSG 1 1.304 0.9 
7 mM GSH/2 mM GSSG 86 0.064 5.6 
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4.2.1.6 Synthesis and folding studies with para-substituted aromatic diethylene 
glycol dithiol (13) 
 
O
S
O
O
O
Tetraethylene disulfide
S
OO
S
O
O
Triethylene disulfide
O
SS
O O
S
O
Diethylene disulfide  
Figure 28. Stable cyclic structure 
 
 After performing the folding experiments above, similar trends in terms of folding 
yield with ortho- and para- series of aromatic dithiols (11, 12, 14, and 15) was observed. 
I thought that the decrease in yield was as a result of the formation of stable cyclic 
disulfides with 11, 12, 14, and 15 (Figure 28, stable disulfides shown only for 14 and 15). 
In order to verify the hypothesis, para-substituted aromatic diethylene glycol dithiol (13) 
was synthesized as shown in Scheme 10 and assumed that dithiol 13 may form a less 
stable cyclic disulfide (Figure 28). Next, the folding studies with dithiol 13 was 
performed. The concentrations of dithiol 13 examined were in the range of 0.5 to 10 mM. 
The folding experiments were carried out in combination with either 0.2 or 2 mM GSSG 
at pH 8.0. (Table 5, Figure 29). However, dithiol 13 showed similar trends as the ortho- 
and para- derivatives of tri- and tetraethylene glycol dithiols (11, 12, 14, and 15). The 
yield decreased with increasing concentrations of dithiol 13. Thus, the decreases in yield 
may not be the result of the formation of a stable cyclic disulfide, but some other factor. 
Next, the role of the thiol present on the aliphatic chain was investigated. 
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Figure 29. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of para-substituted aromatic diethylene glycol 
dithiol (13); (b) under standard conditions or 2 mM GSSG and various concentrations of 
para-substituted aromatic diethylene glycol dithiol (13). (a) (●) 7 mM GSH/ 2 mM 
GSSG (standard conditions), (♦) 0.5 mM 13/0.2 mM GSSG, (▼) 1.0 mM 13/0.2 mM 
GSSG, (▲) 2.0 mM 13/0.2 mM GSSG, (Δ) 3.0 mM 13/0.2 mM GSSG, and () 10.0 
mM 13/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 
mM 13/2 mM GSSG, (▼) 1.0 mM 13/2 mM GSSG, (▲) 2.0 mM 13/2 mM GSSG, (Δ) 
3.0 mM 13/2 mM GSSG, and () 10.0 mM 13/2 mM GSSG. 
 
Table 5. Folding of lysozyme with para-substituted aromatic diethylene glycol dithiol 
(13) at pH 8.0 
 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 13/0.2 mM GSSG 53 0.072 3.79 
1 mM 13/0.2 mM GSSG 36 0.066 2.39 
2 mM 13/0.2 mM GSSG 21 0.065 1.33 
3 mM 13/0.2 mM GSSG 9 0.08 0.71 
10 mM 13/0.2 mM GSSG 0 0 0 
0.5 mM 13/2 mM GSSG 53 0.023 1.21 
    1 mM 13/2 mM GSSG 35 0.055 1.89 
2 mM 13/2 mM GSSG 14 0.131 1.79 
3 mM 13/2 mM GSSG 1 2.849 4.06 
10 mM 13/2 mM GSSG 0 0 0 
7 mM GSH/2 mM GSSG 85 0.051 4.34 
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4.2.1.7 Synthesis and folding studies with aromatic triethylene glycol monothiol (61)                          
To check the role of aliphatic thiol on the yield of lysozyme, aromatic triethylene 
glycol monothiol (61) was synthesized, a compound with a thiol group on the aliphatic 
chain and without a thiol group on the aromatic ring. Monothiol 61 was synthesized by 
treating readily available benzoyl chloride (59) with triethylene glycol disulfide (38) in 
the presence of triethylamine to give compound 60. Compound 60 was purified by 
column chromatography and then reduced with DTT in the presence of triethylamine to 
form monothiol 61 (Scheme 11).  
DTT, Et3N
CH2Cl2
HO
O
S
2
m = 2
Et3N, CH2Cl2
COCl O O
S
O
m = 2
m
O
O
SH
O
m = 2
m
m
2
14%
57%
59
38
60
61  
Scheme 11. Synthesis of aromatic triethylene glycol monothiol (61) 
 
Monothiol 61 was partially soluble in 0.1 M Trizma base buffer (pH 8.0), hence, 
its solubility was determined by Ellman’s method.141 The solubility of monothiol 61 was 
found to be 2 mM at pH 8.0. Thus, the concentrations of monothiol 61 examined were 
0.25, 0.5, and 1 mM. The folding experiments were performed in the presence of either 
0.2 or 2 mM GSSG at pH 8.0 (Table 6, Figure 30). Monothiol 61 showed not only a 
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decrease in the yield but also a decrease in the rate as compared to 7 mM GSH/2 mM 
GSSG. 
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Figure 30. Folding of lysozyme (0.1 mg/mL) at pH 8.0; under standard conditions or 0.2 
mM GSSG and various concentrations of aromatic triethylene glycol monothiol (61) or 2 
mM GSSG and various concentrations of aromatic triethylene glycol monothiol (61). (●) 
7 mM GSH/ 2 mM GSSG (standard conditions), (■) 0.25 mM 61/0.2 mM GSSG, (♦) 0.5 
mM 61/0.2 mM GSSG, (▼) 1.0 mM 61/0.2 mM GSSG, (▲) 0.25 mM 61/2 mM GSSG, 
and (Δ) 0.5 mM 61/2 mM GSSG. 
 
Table 6. Folding of lysozyme with aromatic triethylene glycol monothiol (61) at pH 8.0 
 
 
4.2.1.8 Folding studies with triethylene glycol monothiol (36) 
                                     
HO
O
O
SH
36  
                                    Triethylene glycol monothiol (36)  
Redox buffer A (%) k (min -1) A*k (%/min) 
0.25 mM 61/0.2 mM GSSG 68 0.028 1.9 
0.5 mM 61/0.2 mM GSSG 49 0.019 1.0 
1 mM 61/0.2 mM GSSG 2 0.012 0.02 
0.25 mM 61/2 mM GSSG 65 0.019 1.3 
 0.5 mM 61/2 mM GSSG 54 0.034 1.9 
7 mM GSH/2 mM GSSG 86 0.055 4.7 
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Figure 31. Folding of lysozyme (0.1 mg/mL) at pH 8.0: (a) under standard conditions or 
0.2 mM GSSG and various concentrations of triethylene glycol monothiol (36); (b) under 
standard conditions or 2 mM GSSG and various concentrations of triethylene glycol 
monothiol (36). (a) (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (♦) 0.5 mM 
36/0.2 mM GSSG, (▼) 1.0 mM 36/0.2 mM GSSG, (▲) 2.0 mM 36/0.2 mM GSSG, (Δ) 
3.0 mM 36/0.2 mM GSSG, and () 10.0 mM 36/0.2 mM GSSG; (b) (●) 7 mM GSH/ 2 
mM GSSG (standard conditions), (♦) 0.5 mM 36/2 mM GSSG, (▼) 1.0 mM 36/2 mM 
GSSG, (▲) 2.0 mM 36/2 mM GSSG, (Δ) 3.0 mM 36/2 mM GSSG, and () 10.0 mM 
36/2 mM GSSG. 
 
Table 7. Folding of lysozyme with triethylene glycol monothiol (36) at pH 8.0 
 
 
Finally, folding experiments with triethylene glycol monothiol (36), a compound 
without an aromatic ring were performed. Monothiol 36 was synthesized as shown in 
Redox buffer A (%) k (min -1) A*k (%/min) 
0.5 mM 36/0.2 mM GSSG 72 0.027 1.92 
1 mM 36/0.2 mM GSSG 72 0.029 2.08 
2 mM 36/0.2 mM GSSG 77 0.025 1.88 
3 mM 36/0.2 mM GSSG 68 0.024 1.60 
10 mM 36/0.2 mM GSSG 53 0.008 0.43 
0.5 mM 36/2 mM GSSG 58 0.018 1.0 
    1 mM 36/2 mM GSSG 72 0.020 1.5 
2 mM 36/2 mM GSSG 71 0.034 2.5 
3 mM 36/2 mM GSSG 75 0.037 2.8 
10 mM 36/2 mM GSSG 77 0.036 2.8 
7 mM GSH/2 mM GSSG 80 0.053 4.3 
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Scheme 7. Folding experiments were performed at pH 8.0, using various concentrations 
of monothiol 36 in combination with either 0.2 or 2 mM GSSG (Table 7, Figure 31). 
Folding results with monothiol 36 showed similar folding yields and slightly lower 
folding rates as compared to GSH/GSSG, indicating similar behavior for both aliphatic 
thiols. The slower folding rate with monothiol 36 as compared to GSH may be because of 
the lower thiol pKa of monothiol 36 than that of the GSH.  
In summary, ortho- and para-substituted aromatic ethylene glycol dithiols (11, 
12, 14, and 15) showed a decrease in the yield of native lysozyme relative to the 
traditional conditions of GSH and GSSG. The initial hypothesis to explain the decrease in 
yield was that dithiols 11, 12, 14, and 15 may form stable cyclic disulfides. To test the 
hypothesis, para-substituted aromatic diethylene glycol dithiol (13) was synthesized and 
examined for its ability to fold reduced lysozyme. However, the initial hypothesis was 
not substantiated as dithiol 13 showed similar results in terms of yield as dithiols 11, 12, 
14, and 15. Next, the role of the aliphatic thiol on the folding rate and yield of lysozyme 
was investigated. To check the role of aliphatic thiol, two compounds were synthesized, 
an aromatic triethylene glycol monothiol (61), a compound with a thiol on the aliphatic 
chain and without a thiol on the aromatic ring, and triethylene glycol monothiol (36). 
Both compounds (61 and 36) were then examined for their ability to fold reduced 
lysozyme. Monothiol 61 decreased the folding rate as well as yield of lysozyme. On the 
contrary, monothiol 36 showed similar results as GSH/GSSG. Thus, an aliphatic thiol 
group without an aromatic ring does not have any effect on the yield, whereas a thiol 
group on an aliphatic chain attached to an aromatic ring decreases the yield. To conclude, 
the decrease in the yield of native lysozyme with ortho- and para-substituted aromatic 
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ethylene glycol dithiols (11, 12, 14, and 15) may be because of the presence of the thiol 
group on an aliphatic chain attached to an aromatic ring. 
4.3 Di Quaternary ammonium aromatic dithiols (16 and 17) 
 In the first series of aromatic dithiols (ortho- and para-series), one thiol group 
was present on the aromatic ring and a second thiol group was present on the aliphatic 
chain. The results of the folding experiments with ortho- and para-substituted aromatic 
ethylene glycol dithiols (11, 12, 14, and 15) showed a decrease in the in vitro folding rate 
and yield as compared to standard conditions. Thus, a new series of aromatic dithiols 
were designed which should improve the in vitro folding rate and yield of lysozyme. The 
new series of aromatic dithiols were designed on the basis of a previously synthesized 
aromatic quaternary ammonium salt monothiol (Mono QAS) (3). Mono QAS 3 increased 
the folding rate and yield of reduced lysozyme (0.1 mg/mL as well at 1 mg/mL).37,38 
Hence, new aromatic dithiols (16 and 17) similar in structure to the Mono QAS 3 were 
designed, having one thiol group on each of the two aromatic rings and the two aromatic 
rings connected by a hydrocarbon chain containing two quaternary ammonium groups. 
The criteria for selecting aromatic di quaternary ammonium salt dithiols (Di QAS) (16 
and 17) were water solubility and low thiol pKa values, the same criteria as those used for 
dithiols 11, 12, 14, and 15. Furthermore, Di QAS 16 and Di QAS 17 were compared with 
Mono QAS 3 to check the effect of the second thiol group on folding rate and yield of a 
disulfide containing protein. 
4.3.1 Synthesis of aromatic di quaternary ammonium salt dithiols (16 and 17) 
 Next, Di QAS 16 and Di QAS 17 were synthesized from brominated compound 
(25) in two simple steps, a coupling reaction followed by a hydrolysis reaction. The 
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brominated compound (25) was synthesis as shown in Scheme 4. The brominated 
compound (25) was treated with N,N,N',N'-tetramethyl-1,3-propane diamine (63) or 
N,N,N',N'-tetramethyl-1,6-hexane diamine (65) to form compound (67) and (69), 
respectively. Compounds (67) and (69) were then hydrolyzed with 1:1 HBr:H2O at 130 
oC for 90 min to give Di QAS 16 and Di QAS 17, respectively, (Scheme 12).                      
S
Br
O
S
N
O
N Nm
CH3CN
N
S
O
BrBr
SH
N N
SH
BrBr
1:1 HBr:H2O
130 oC, 90 min
m = 1,4
m
m = 1, 4
m = 1, 4
93%, 51%
95%, 99% m
25
63, 65
67, 69
16, 17  
Scheme 12. Synthesis of aromatic di quaternary ammonium salt dithiols (16 and 17) 
 
4.3.2 Folding of lysozyme with Di QAS (16 and 17) 
 Di QAS 16 and Di QAS 17 in various concentrations along with 2 mM GSSG 
were utilized for the folding of reduced lysozyme (0.1 mg/mL) at pH 7.0 and 8.0. These 
folding experiments were conducted simultaneously with the standard condition, 7 mM 
GSH and 2 mM GSSG. The folding of lysozyme was followed using the recovery of 
enzymatic activity as described for the dithiols 11, 12, 14, and 15. Initially, folding of  
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Table 8. Folding of lysozyme (0.1 mg/mL) with DI QAS 16 and GSH at pH 7.0 and 8.0 
 
 
reduced lysozyme was performed using 1, 2, 3, 7, and 10 mM Di QAS 16 or Di QAS 17 
in the presence of 2 mM GSSG at pH 7.0 and 8.0. Both Di QAS 16 and Di QAS 17 were 
soluble ( >100 mM) in 0.1 M bis tris propane-HCl buffer (pH 7.0) and 0.1 M Tris-HCl 
buffer (pH 8.0). The folding of lysozyme in the presence of Di QAS 16 and Di QAS 17 
was compared by fitting the data to a single exponential function [y =A(1- e –kt)], similar 
to that used for the dithiols 11, 12, 14, and 15 (Tables 8 and 9). Preliminary studies 
suggested that at pH 7.0, Di QAS 16 and Di QAS 17 increased the folding rate 
significantly with increasing concentration as compared to GSH/GSSG. However, at pH 
8.0, below 7 mM Di QAS 16 and below 3 mM of Di QAS 17 the folding rate was slower, 
 pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
1 mM 16/2 mM GSSG 87 0.010 0.9 
2 mM 16/2mM GSSG 84 0.016  1.4   
3 mM 16/2 mM GSSG 87  0.025  2.2  
7 mM 16/2 mM GSSG 75  0.042  3.2  
10 mM 16/2 mM GSSG 58  0.1  5.8  
7 mM GSH/2 mM GSSG 91  0.007 0.6  
 pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
1 mM 16/2 mM GSSG 94 0.013 1.2 
2 mM 16/2mM GSSG 98 0.006  0.6   
3 mM 16/2 mM GSSG 92  0.018  1.7  
7 mM 16/2 mM GSSG 85  0.034  2.9  
10 mM 16/2 mM GSSG 61  0.065 4.0  
7 mM GSH/2 mM GSSG 90  0.045 4.0  
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while at 10 mM of Di QAS 16 and above 7 mM Di QAS 17 the folding rate was 
significantly faster as compared to GSH/GSSG. At pH 7.0 and 8.0, Di QAS 17 showed 
similar yields of native lysozyme at all concentrations as GSH/GSSG. However, with Di 
QAS 16 at both pH 7.0 and 8.0, the folding yield decreased with increasing concentration 
as compared to GSH/GSSG. 
Table 9. Folding of lysozyme (0.1 mg/mL) with DI QAS 17 and GSH at pH 7.0 and 8.0 
 
 
Next, folding experiments at high lysozyme concentration (1 mg/mL) using Di 
QAS 16 and Di QAS 17 at pH 7.0 and 8.0 were performed. Preliminary studies were 
performed to find the best concentration of Di QAS 16, Di QAS 17, and GSSG at both 
pH 7.0 and 8.0. Herein, GSSG was selected instead of the respective aromatic disulfides, 
 pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
1 mM 17/2 mM GSSG 73 0.013 0.9 
2 mM 17/2mM GSSG 71 0.028  2.0   
3 mM 17/2 mM GSSG 73  0.034  2.4  
7 mM 17/2 mM GSSG 72  0.067  4.8  
10 mM 17/2 mM GSSG 68  0.081 5.5  
7 mM GSH/2 mM GSSG 67  0.008 0.6  
pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
1 mM 17/2 mM GSSG 68 0.013 0.9 
2 mM 17/2mM GSSG 78 0.020  1.6   
3 mM 17/2 mM GSSG 78  0.030 2.2  
7 mM 17/2 mM GSSG  72 0.064 4.6  
10 mM 17/2 mM GSSG 73  0.083 6.0  
7 mM GSH/2 mM GSSG 72  0.040 2.9  
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as the aromatic disulfides were partially soluble in the 0.1 M bis tris propane-HCl buffer 
(pH 7.0) and 0.1 M Tris-HCl buffer (pH 8.0). Herein, the concentrations of Di QAS 16 
and Di QAS 17 screened were 10, 20, 40, 70, and 100 mM, and the concentrations of 
GSSG examined were 0.5, 1, and 2 mM. In addition, the concentrations of Di QAS 16 
examined with 2 mM GSSG were 1, 2, 3, 7, and 10 mM. Concentrations of Di QAS 16 
and Di QAS 17 were selected to screen a wide range of concentrations. At pH 7.0 and 
8.0, the two best combinations of each of Di QAS 16/GSSG and Di QAS 17/GSSG were 
selected. At pH 7.0, the best concentration pairs for Di QAS 16 were 10 mM 16/1 mM 
GSSG and 20 mM 16/1 mM GSSG whereas at pH 8.0, the best concentration pairs were 
20 mM 16/1 mM GSSG and 40 mM 16/1 mM GSSG. On the other hand at pH 7.0, the 
best concentration pairs for Di QAS 17 were found to be 10 mM 17/0.5 mM GSSG and 
10 mM 17/1 mM GSSG whereas at pH 8.0, the best pairs were 10 mM 17/1 mM GSSG 
and 20 mM 17/1 mM GSSG.   
 To investigate the effect of the second thiol group on the folding rates and yields 
of reduced lysozyme, folding studies with Di QAS 16 and Di QAS 17 were performed 
simultaneously with Mono QAS 3. Folding of reduced lysozyme with various 
concentrations of Mono QAS 3 and various concentrations of GSSG were performed at 
both pH 7.0 and 8.0 to find the best combination of Mono QAS 3/GSSG. Herein, the 
concentrations of Mono QAS 3 selected were 10, 20, 40, 70, and 100 mM and the 
concentrations of GSSG selected were 0.5, 1, and 2 mM. The best combination pair at pH 
7.0 and 8.0 was found to be 40 mM 3/1 mM GSSG.  
 Next, comparative folding studies with the best combination pairs of Di QAS 
16/GSSG, Di QAS 17/GSSG and Mono QAS 3/GSSG were conducted simultaneously 
  102 
 
with 7 mM GSH/2 mM GSSG at both pH 7.0 and 8.0 (Figure 32) The data were fit to a 
single exponential function, y = A(1- e –kt). The concentration of thiol which provided the 
highest value of the initial folding rate, A*k, was defined as optimal. The A, k, and A*k   
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Figure 32. Folding of lysozyme (1 mg/mL) : (a) at pH 7.0, (●) 7 mM GSH/ 2 mM GSSG 
(standard conditions), (■) 40 mM 3/1 mM GSSG, (♦) 10 mM 16/1 mM GSSG, (▼) 20 
mM 16/1 mM GSSG, (▲) 10 mM 17/0.5 mM GSSG, and (Δ) 10.0 mM 17/1 mM GSSG; 
(b) at pH 8.0, (●) 7 mM GSH/ 2 mM GSSG (standard conditions), (■) 40 mM 3/1 mM 
GSSG, (▼) 20 mM 16/1 mM GSSG, () 40 mM 16/1 mM GSSG, (Δ) 10 mM 17/1 mM 
GSSG, and () 20.0 mM 17/1 mM GSSG. 
 
values at pH 7.0 and 8.0 are shown in the table 10. The results indicate a significant 
increase in the folding rate and yields for aromatic monothiol 3/GSSG, dithiol 16/GSSG, 
and dithiol 17/GSSG relative to GSH/GSSG at pH 7.0. The folding rate increase from 11 
to 17 times and the yields increase from 26 to 42% relative to GSH/GSSG. The best 
folding rate was observed with 40 mM 3/1 mM GSSG, whereas the best yield was 
observed with 20 mM 16/1 mM GSSG. While comparing aromatic dithiols versus 
aromatic monothiols, aromatic monothiol (40 mM 3/1 mM GSSG) showed a significant 
increase in folding rate as compared to aromatic dithiols (10 mM 16/1 mM GSSG and 20 
mM 16/1 mM GSSG). However, aromatic dithiol (20 mM 16/1 mM GSSG) significantly 
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increase the yield of native lysozyme as compared to aromatic monothiol (40 mM 3/1 
mM GSSG). The A*k  values illustrate that best combination of aromatic thiol/GSSG 
concentrations at pH 7.0 were 40 mM 3/1 mM GSSG and 20 mM 16/1 mM GSSG. The 
A*k  values for 40 mM 3/1 mM GSSG and 20 mM 16/1 mM GSSG were 28 and 24 
times, respectively, greater than that of GSH/GSSG at pH 7.0 and a protein concentration 
of 1 mg/mL.  
Table 10. Folding of lysozyme (1 mg/mL) with Mono QAS 3, Di QAS 16, Di QAS 17, 
and GSH at pH 7.0 and 8.0 
 
 
 At pH 8.0, Figure 32 illustrates a substantial increase in the folding rate and yield 
with an Mono QAS 3 and Di QAS 16 as compared to GSH/GSSG (Table 10). The yield 
improvements were as much as 15%, with the best being 20 mM 16/1 mM GSSG. The 
pH 7.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
40 mM 3/1 mM GSSG 82 ± 3 0.017 ± 0.002 1.4 ± 0.2 
10 mM 16/1 mM GSSG 83 ± 5 0.012 ± 0.001 1.0 ± 0.2  
20 mM 16/1 mM GSSG 86 ± 4 0.015 ± 0.003 1.2 ± 0.3 
10 mM 17/0.5 mM GSSG 70 ± 5 0.013 ± 0.002 0.9 ± 0.2 
10 mM 17/1 mM GSSG 74 ± 6 0.011 ± 0.001 0.8 ± 0.2 
7 mM GSH/2 mM GSSG 44 ± 2 0.001 ± 0.0002 0.05 ± 0.01 
pH 8.0 
Redox buffer A (%) k (min -1) A*k (%/min) 
40 mM 3/1 mM GSSG 81 ± 6 0.018 ± 0.002 1.5 ± 0.1 
20 mM 16/1 mM GSSG 88 ± 5 0.022 ± 0.003 2.0 ± 0.3  
40 mM 16/1 mM GSSG  77 ± 10 0.023 ± 0.010 1.9 ± 1.0 
10 mM 17/1 mM GSSG 78 ± 6 0.016 ± 0.002 1.3 ± 0.2 
20 mM 17/1 mM GSSG  49 ± 26 0.017 ± 0.002 0.8 ± 0.4 
7 mM GSH/2 mM GSSG 73 ± 4 0.003 ± 0.001 0.19 ± 0.02 
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folding rates with Mono QAS 3 and Di QAS 16 were increased up to eight times 
compared with 7 mM GSH/2 mM GSSG, the best being 40 mM 16/1 mM GSSG. 
Comparison of aromatic monothiol (Mono QAS 3) versus aromatic dithiol (Di QAS 16) 
at pH 8.0, revealed that Di QAS 16 were better than Mono QAS 3 in terms of rate and 
yield. Aromatic dithiol (40 mM 16/1 mM GSSG) was better than aromatic monothiol (40 
mM 3/1 mM GSSG) in terms of folding rate, whereas aromatic dithiol (20 mM 16/1 mM 
GSSG) showed significant increase in yield as compared to aromatic monothiol (40 mM 
3/1 mM GSSG). Overall, aromatic dithiol (20 mM 16/1 mM GSSG) was significantly 
better in terms of rate and yield as compared to aromatic monothiol (40 mM 3/1 mM 
GSSG). At higher concentration of Di QAS 17, 20 mM 17/1 mM GSSG, although the 
rate was 6 times better than that of GSH/GSSG, the yield went down significantly. The 
decrease in the yield with 20 mM 17/1 mM GSSG was because of precipitation of the 
protein as seen by the naked eye. At pH 8.0 and a protein concentration of 1 mg/mL, 20 
mM 16/1 mM GSSG and 40 mM 16/1 mM GSSG showed as much as 10 times better A*k 
relative to 7 mM GSH/2 mM GSSG. 
4.4 pKa Values of aromatic monothiols and aromatic dithiols 
 The pKa values of aromatic monothiols and aromatic dithiols were determined by 
measuring the change in the UV-vis spectra as a function of pH. Buffers with pH values 
within 1.5 units of the predicted pKa values of the thiol were selected. The UV-vis 
spectrum of the thiol in each buffer was then obtained. The absorbance values at max of 
either thiol or thiolate were then plotted against buffer pH and the resulting curve were 
analyzed by numerical analysis. The thiol pKa values of the ortho-substituted aromatic 
dithiols as well as triethylene aromatic monothiol were in the range of 6.8 to 7.2 (Table 
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11, Figure 34). The thiol pKa values of the para-substituted aromatic dithiols as well as 
Di QAS aromatic dithiols were in the range of 5.3 to 5.5 (Table 11, Figure 33). Figure 34 
illustrates UV-vis spectra of para-substituted aromatic tetraethylene glycol dithiol (15) in 
various pH buffers. 
Table 11. pKa Values of aromatic monothiols and aromatic dithiols 
 
Compound Substitution pKa 
Diethylene glycol dithiol (ortho) 
10  
o-HSPhCO2(CH2)2O(CH2)2SH 7.1 
Triethylene glycol 
dithiol (ortho) 11 
o-HSPhCO2(CH2CH2O)2CH2CH2SH 7.2 
Tetraethylene glycol dithiol 
(ortho) 12 
o-HSPhCO2(CH2CH2O)3CH2CH2SH 7.0 
Diethylene glycol 
dithiol (para) 13 
p-HSPhCO2(CH2)2O(CH2)2SH 5.4 
Tetraethylene glycol 
dithiol (para) 15 
p-HSPhCO2(CH2CH2O)3CH2CH2SH 5.5 
Mono QAS (para) 3 p-HSPhCH2N+(CH3)3 5.4 
Di QAS (para) 16 p-HSPhCH2N+(CH3)2(CH2)3N+(CH3)2CH2-p-
PhSH 
5.3 
Di QAS (para) 17 p-HSPhCH2N+(CH3)2(CH2)6N+(CH3)2CH2-p-
PhSH 
5.4 
 
 
    
0
1
2
4 6 8 10
Ab
so
rb
an
ce
pH
(a) Diethylene dithiol ( ortho) 10
   
0
1
2
4 6 8 10
Ab
so
rb
an
ce
pH
(b) Triethylene dithiol ( ortho) 11
 
  106 
 
    
0
1
2
4 6 8 10
Ab
so
rb
an
ce
pH
(c) Tetraethylene dithiol ( ortho) 12
   
0
1
2
2 4 6 8
Ab
so
rb
an
ce
pH
(d) Diethylene dithiol ( para) 13
 
     
0
1
2
2 4 6 8
A
bs
or
ba
nc
e
pH
(e) Tetraethylene dithiol ( para) 15
   
0
1
2
2 4 6 8
Ab
so
rb
an
ce
pH
(f) Mono QAS 3
 
     
0
1
2
2 4 6 8
Ab
so
rb
an
ce
pH
(g) Di QAS 16
    
0
1
2
2 4 6 8
Ab
so
rb
an
ce
pH
(h) Di QAS 17
 
Figure 33. Determination of pKa values a) diethylene glycol dithiol (ortho) 10, b) 
triethylene glycol dithiol (ortho) 11, c) tetraethylene glycol dithiol ortho 12, d) diethylene 
glycol dithiol (para) 13, e) tetraethylene glycol dithiol (para) 15, f) Mono QAS 3, g) Di 
QAS 16, h) Di QAS 17. 
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Figure 34. UV-vis spectra of para-substituted aromatic tetraethylene glycol dithiol (15) 
in various pH buffers. 
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Chapter 5 
 Conclusion 
Project 1 
1) Aromatic monothiols, such as 4-mercaptobenzoic acid (1), 4-
mercaptobenzylphosphonic acid (2), quaternary ammonium salt (3), and 4-
mercaptobenzenesulfonic acid (4), and their corresponding disulfides (5-8) were 
synthesized on a multigram scale. 
2) Disulfides of 4-mercaptobenzylphosphonic acid (6), quaternary ammonium salt (7), 
and 4-mercaptobenzenesulfonic acid (8) were utilized by Ms. Shweta Mandumula  to fold 
BPTI, in particular N* to N. The results demonstrated that small molecule aromatic 
disulfides increase the folding rate constant of N* to N by 100-3000 fold as compared to 
GSSG. Additionally, the results showed that N* does undergo direct oxidation to N, 
which was proposed earlier by Kim and Creighton not to occur. 
3) The 4-Mercaptobenzylphosphonic acid (2), quaternary ammonium salt (3), and their 
corresponding disulfides (6 and 7) were utilized by Dr. David Madar to fold lysozyme at 
high protein concentration (1 mg/mL). The results revealed that aromatic thiols increase 
the folding rate up to 11 times and improve the yield between 20 and 40% as compared to 
GSH/GSSG at pH 7.0. Furthermore, at pH 8.0, the folding rate was increased up to 7 
times and the yield was improved up to 25% as compared to GSH/GSSG. 
4) The disulfide of 4-mercaptobenzoic acid (5) was used to synthesize a series of para- 
substituted aromatic ethylene glycol dithiols (13-15). 
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Project 2 
5) Two series of ortho- and para-substituted aromatic ethylene glycol dithiols (9-15) 
were synthesized. Dithiols (11-15) were then checked for effect on the folding of 
lysozyme at pH 7.0 and 8.0. The ortho- and para-substituted aromatic ethylene glycol 
dithiols (11-15) showed a decrease in yield at both pH 7.0 and 8.0 as compared to 
GSH/GSSG. The decrease in yield of native lysozyme may be because of the presence of 
a thiol group on an aliphatic chain attached to an aromatic ring. 
 
Project 3 
6) Finally, Di QAS 16 and Di QAS 17 were synthesized on a multigram scale in two easy 
steps from brominated intermediate (25) without any purification step except extraction.  
7) Mono QAS 3, Di QAS 16, and Di QAS 17 were then tested for their ability to fold 
lysozyme at high protein concentration (1 mg/mL) at both pH 7.0 and 8.0.  
 At pH 7.0, Mono QAS 3, Di QAS 16, and Di QAS 17 increased the folding rate 
and yield from 11 to 17 times and 26 to 42%, respectively, relative to GSH/GSSG. While 
comparing aromatic dithiols versus aromatic monothiols, aromatic monothiol (40 mM 3/1 
mM GSSG) showed a significant increase in folding rate as compared to aromatic 
dithiols (10 mM 16/1 mM GSSG and 20 mM 16/1 mM GSSG). However, aromatic dithol 
(20 mM 16/1 mM GSSG) significantly increase the yield of native lysozyme as compared 
to aromatic monothiol (40 mM 3/1 mM GSSG). 
 At pH 8.0, with Mono QAS (3), Di QAS 16, and Di QAS 17, the yield 
improvements were as much as 15%, while the folding rate enhancements were up to 8 
times compared to GSH/GSSG. Comparison of aromatic monothiol versus aromatic 
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dithiols revealed that aromatic dithiol (16) was better than aromatic monothiol (3) in 
terms of rate and yield. Aromatic dithiol (40 mM 16/1 mM GSSG) was better than 
aromatic monothiol (40 mM 3/1 mM GSSG) in terms of folding rate, whereas aromatic 
dithiol (20 mM 16/1 mM GSSG) showed a significant increase in yield as compared to 
aromatic monothiol (40 mM 3/1 mM GSSG). Overall, aromatic dithiol (16) was 
significantly better in terms of rate and yield as compared to aromatic monothiol (3).  
8) In conclusion, Di QAS (aromatic dithiol) significantly increase the in vitro folding 
yield of lysozyme as compared to Mono QAS (aromatic monothiol) at both pH 7.0 and 
8.0 and high protein concentration (1 mg/mL). Moreover, Di QAS (aromatic dithiol) and 
Mono QAS (aromatic monothiol) are better than aliphatic thiol such as glutathione in 
terms of folding rate and yield at both pH 7.0 and 8.0 and high protein concentration (1 
mg/mL). Thus, enhancement of the folding rate and yield achieved in in vitro protein 
folding at high protein concentration will decrease the volume of renaturation solution 
required for large scale processes and consequently reduce the processing time and cost. 
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